| For: | Raza A, Sood GK. Hepatocellular carcinoma review: Current treatment, and evidence-based medicine. World J Gastroenterol 2014; 20(15): 4115-4127 [PMID: 24764650 DOI: 10.3748/wjg.v20.i15.4115] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i15/4115.htm |
| Number | Citing Articles |
| 1 |
Kai Yu, Yunhua Mei, Zhongyi Wang, Bo Liu, Ming Deng. LncRNA LINC00924 upregulates NDRG2 to inhibit epithelial‐mesenchymal transition via sponging miR‐6755‐5p in hepatitis B virus‐related hepatocellular carcinoma. Journal of Medical Virology 2022; 94(6) doi: 10.1002/jmv.27578
|
| 2 |
Jingxiong Lu, Jin Wang, Daishun Ling. Surface Engineering of Nanoparticles for Targeted Delivery to Hepatocellular Carcinoma. Small 2018; 14(5) doi: 10.1002/smll.201702037
|
| 3 |
Mandeep Kumar Singh, Bhrigu Kumar Das, Sandeep Choudhary, Deepak Gupta, Umesh K Patil. Diabetes and hepatocellular carcinoma: A pathophysiological link and pharmacological management. Biomedicine & Pharmacotherapy 2018; 106 doi: 10.1016/j.biopha.2018.06.095
|
| 4 |
Ilkyu Park, Hyo-Bin Lee, Nakyoung Kim, Sugi Lee, Kunhyang Park, Mi-Young Son, Hyun-Soo Cho, Dae-Soo Kim. Uncovering gene expression signatures and diagnostic – Biomarkers in hepatocellular carcinoma through multinomial logistic regression analysis. Journal of Biotechnology 2024; 395 doi: 10.1016/j.jbiotec.2024.09.003
|
| 5 |
Jiangwei Liu, Xiaocheng Li, Jianzhao Huang, Yan Liu. Matrix metalloproteinase 2 knockdown suppresses the proliferation of HepG2 and Huh7 cells and enhances the cisplatin effect. Open Medicine 2019; 14(1) doi: 10.1515/med-2019-0039
|
| 6 |
Yan Liu, Ruibao Liu, Ping Wang, Shijie Li, Haiyang Shen. Percutaneous implantation of 125iodine seeds for treatment of portal vein tumor thrombosis in hepatocellular carcinoma. Medical Oncology 2015; 32(8) doi: 10.1007/s12032-015-0657-0
|
| 7 |
Toshiaki Nakano, Chao-Long Chen, I-Hsuan Chen, Hui-Peng Tseng, Kuei-Chen Chiang, Chia-Yun Lai, Li-Wen Hsu, Shigeru Goto, Chih-Che Lin, Yu-Fan Cheng. Overexpression of miR-4669 Enhances Tumor Aggressiveness and Generates an Immunosuppressive Tumor Microenvironment in Hepatocellular Carcinoma: Its Clinical Value as a Predictive Biomarker. International Journal of Molecular Sciences 2023; 24(9) doi: 10.3390/ijms24097908
|
| 8 |
Hyosun Tak, Hoin Kang, Eunbyul Ji, Youlim Hong, Wook Kim, Eun Kyung Lee. Potential use of TIA-1, MFF, microRNA-200a-3p, and microRNA-27 as a novel marker for hepatocellular carcinoma. Biochemical and Biophysical Research Communications 2018; 497(4) doi: 10.1016/j.bbrc.2018.02.189
|
| 9 |
|
| 10 |
Zuzanna Sas, Ewa Cendrowicz, Isabel Weinhäuser, Tomasz P. Rygiel. Tumor Microenvironment of Hepatocellular Carcinoma: Challenges and Opportunities for New Treatment Options. International Journal of Molecular Sciences 2022; 23(7) doi: 10.3390/ijms23073778
|
| 11 |
Fulufhelo Tabitha Ramaite, Sanah Malomile Nkadimeng. Targeting inflammatory pathways in hepatocellular carcinoma: recent developments. Discover Oncology 2025; 16(1) doi: 10.1007/s12672-025-03035-8
|
| 12 |
Changwei Dou, Qiuran Xu, Jie Liu, Yufeng Wang, Zhenyu Zhou, Weifeng Yao, Kai Jiang, Jian Cheng, Chengwu Zhang, Kangsheng Tu. SHMT1 inhibits the metastasis of HCC by repressing NOX1-mediated ROS production. Journal of Experimental & Clinical Cancer Research 2019; 38(1) doi: 10.1186/s13046-019-1067-5
|
| 13 |
Bushan Xie, Xingxing He, Guihai Guo, Xiao Zhang, Jinping Li, Jianping Liu, Yingbo Lin. High-throughput screening identified mitoxantrone to induce death of hepatocellular carcinoma cells with autophagy involvement. Biochemical and Biophysical Research Communications 2020; 521(1) doi: 10.1016/j.bbrc.2019.10.114
|
| 14 |
Guorong Jia, Juno Van Valkenburgh, Austin Z. Chen, Quan Chen, Jindian Li, Changjing Zuo, Kai Chen. Recent advances and applications of microspheres and nanoparticles in transarterial chemoembolization for hepatocellular carcinoma. WIREs Nanomedicine and Nanobiotechnology 2022; 14(2) doi: 10.1002/wnan.1749
|
| 15 |
Sahar A. Helmy, Mohamed El-Mesery, Amro El-Karef, Laila A. Eissa, Amal M. El Gayar. Thymoquinone upregulates TRAIL/TRAILR2 expression and attenuates hepatocellular carcinoma in vivo model. Life Sciences 2019; 233 doi: 10.1016/j.lfs.2019.116673
|
| 16 |
Mélissa Léveillé, Jennifer L. Estall. Mitochondrial Dysfunction in the Transition from NASH to HCC. Metabolites 2019; 9(10) doi: 10.3390/metabo9100233
|
| 17 |
Haneulsaem Shin, Yeon Woo Jung, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Yeun-Yoon Kim, Jin-Young Choi, Seung Up Kim. Risk assessment of hepatocellular carcinoma development for indeterminate hepatic nodules in patients with chronic hepatitis B. Clinical and Molecular Hepatology 2019; 25(4) doi: 10.3350/cmh.2018.0103
|
| 18 |
KUO-SHYANG JENG, CHI-JUEI JENG, WEN-JUEI JENG, I-SHYAN SHEEN, SHIH-YUN LI, ZIH-HANG HUNG, HSIN-I HSIAU, MING-CHE YU, CHIUNG-FANG CHANG. Liver epithelial cells inhibit proliferation and invasiveness of hepatoma cells. Oncology Reports 2016; 35(3) doi: 10.3892/or.2015.4478
|
| 19 |
Yulia A. Nevzorova, Johannes Grossmann, Christian Trautwein. Anti-tumorigenic and anti-angiogenic effects of natural conifer Abies sibirica terpenoids in vivo and in vitro. Biomedicine & Pharmacotherapy 2017; 89 doi: 10.1016/j.biopha.2017.02.035
|
| 20 |
Niklas Verloh, Isabel Jensch, Lukas Lürken, Michael Haimerl, Marco Dollinger, Philipp Renner, Philipp Wiggermann, Jens Martin Werner, Florian Zeman, Christian Stroszczynski, Lukas Philipp Beyer. Similar complication rates for irreversible electroporation and thermal ablation in patients with hepatocellular tumors. Radiology and Oncology 2019; 53(1) doi: 10.2478/raon-2019-0011
|
| 21 |
Masoumeh Hajizadeh, Farnaz Hajizadeh, Sevil Ghaffarei, Mohammad Amin Doustvandi, Khadijeh Hajizadeh, Seyyed Mohammad Yaghoubi, Fateme Mohammadnejad, Nadia Allahyarzadeh Khiabani, Pegah Mousavi, Behzad Baradaran. MicroRNAs and their vital role in apoptosis in hepatocellular carcinoma: miRNA-based diagnostic and treatment methods. Gene 2023; 888 doi: 10.1016/j.gene.2023.147803
|
| 22 |
Jayoung Lee, Ju Hye Lee, Hanbin Yoon, Ho Jeong Lee, Hosang Jeon, Jiho Nam. Extraordinary radiation super-sensitivity accompanying with sorafenib combination therapy: what lies beneath?. Radiation Oncology Journal 2017; 35(2) doi: 10.3857/roj.2017.00262
|
| 23 |
Shimaa I. A. Mohamed, Amgad El Shaffai, Shaymaa M.M. Yahya, Walaa S.A. Mettwally, Ghada H. Elsayed. Cytotoxicity and apoptotic effect of Methanolic extract of Red Sea seagrass, Enhalus acoroides (Linn.f.) Royle, against hepatocellular carcinoma cell line (HepG-2) and phytochemical characterization. Advances in Traditional Medicine 2025; 25(2) doi: 10.1007/s13596-024-00775-w
|
| 24 |
Jeffery Fairman, Katherine H. Liu, Stephan Menne. Prevention of liver tumor formation in woodchucks with established hepatocellular carcinoma by treatment with cationic liposome-DNA complexes. BMC Cancer 2017; 17(1) doi: 10.1186/s12885-017-3163-2
|
| 25 |
RUNZHE CHEN, ZENGXIN GAO, XIAOTAO WU, JOS L. CAMPBELL, PEI ZHANG, BAOAN CHEN. Hepatocellular carcinoma presenting as thoracic spinal canal metastasis with no clinical primary foci: A report of a rare case and review of the literature. Oncology Letters 2015; 10(4) doi: 10.3892/ol.2015.3569
|
| 26 |
Shaikh Afaq, Jayesh M. Soni, Anil K. Pillai. Liver Diseases. 2020; doi: 10.1007/978-3-030-24432-3_63
|
| 27 |
. 2020; doi: 10.70675/82c8a516zff04z478dzac4fzb5deccaf38ee
|
| 28 |
Chao Hu, Shi-Qiang Shen, Zhong-Hui Cui, Zu-Bing Chen, Wei Li. Effect of microRNA-1 on hepatocellular carcinoma tumor endothelial cells. World Journal of Gastroenterology 2015; 21(19): 5884-5892 doi: 10.3748/wjg.v21.i19.5884
|
| 29 |
Rodrigo Riedel, Antonio Pérez-Pérez, Antonio Carmona-Fernández, Mariana Jaime, Roberto Casale, José Luis Dueñas, Pilar Guadix, Víctor Sánchez-Margalet, Cecilia L. Varone, Julieta L. Maymó. Human amniotic membrane conditioned medium inhibits proliferation and modulates related microRNAs expression in hepatocarcinoma cells. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-50648-5
|
| 30 |
Aakriti Garg, Santanu Kaity, Manisha Thakur, Ashok Kumar Datusalia, Anoop Kumar. Therapeutic Nanocarriers in Cancer Treatment: Challenges and Future Perspective. 2023; doi: 10.2174/9789815080506123010016
|
| 31 |
|
| 32 |
Rituraj Bharadwaj, Achyut Bora, Kangkana Sharma.
Liposomal delivery of
Annona muricata
leaves extract for the treatment of hepatocellular carcinoma
. Drug Development and Industrial Pharmacy 2024; 50(11) doi: 10.1080/03639045.2024.2433618
|
| 33 |
Min Li, Jie Wang, Jieqiong Song, Feng Shen, Lujun Song, Xiaoling Ni, Tao Suo, Han Liu, Ming Zhong, Houbao Liu, Achim Langenbucher. Preoperative ICG Test to Predict Posthepatectomy Liver Failure and Postoperative Outcomes in Hilar Cholangiocarcinoma. BioMed Research International 2021; 2021(1) doi: 10.1155/2021/8298737
|
| 34 |
Chaobin He, Yu Zhang, Xiaojun Lin. Increased Overall Survival and Decreased Cancer-Specific Mortality in Patients with Hepatocellular Carcinoma Treated by Transarterial Chemoembolization and Human Adenovirus Type-5 Combination Therapy: a Competing Risk Analysis. Journal of Gastrointestinal Surgery 2018; 22(6) doi: 10.1007/s11605-018-3703-3
|
| 35 |
Mahfoozur Rahman, Sarwar Beg, Khalid S. Alharbi, Nabil K. Alruwaili, Nasser Hadal Alotaibi, Abdulaziz I. Alzarea, Waleed H. Almalki, Sattam Khulaif Alenezi, Waleed M. Altowayan, Mohammed S. Alshammari, Muhammad Afzal, Shakir Saleem, Vikas Kumar. Implications of Solid Lipid Nanoparticles of Ganoderic Acid for the Treatment and Management of Hepatocellular Carcinoma. Journal of Pharmaceutical Innovation 2021; 16(2) doi: 10.1007/s12247-020-09450-4
|
| 36 |
Onur C. Kutlu, Jennifer A. Chan, Thomas A. Aloia, Yun S. Chun, Ahmed O. Kaseb, Guillaume Passot, Suguru Yamashita, Jean‐Nicolas Vauthey, Claudius Conrad. Comparative effectiveness of first‐line radiofrequency ablation versus surgical resection and transplantation for patients with early hepatocellular carcinoma. Cancer 2017; 123(10) doi: 10.1002/cncr.30531
|
| 37 |
Ahmed Fekri, Eman M. Keshk, Abdel-Galil M. Khalil, Israa Taha. Synthesis of novel antioxidant and antitumor 5-aminopyrazole derivatives, 2D/3D QSAR, and molecular docking. Molecular Diversity 2022; 26(2) doi: 10.1007/s11030-021-10184-9
|
| 38 |
Sayan Mullick Chowdhury, Taehwa Lee, Sunitha V. Bachawal, Rammohan Devulapally, Lotfi Abou-Elkacem, Tristan Alan Yeung, Jennifer Wischhusen, Lu Tian, Jeremy Dahl, Ramasamy Paulmurugan, Juergen Karl Willmann. Longitudinal assessment of ultrasound-guided complementary microRNA therapy of hepatocellular carcinoma. Journal of Controlled Release 2018; 281 doi: 10.1016/j.jconrel.2018.05.009
|
| 39 |
Anthony Tanoto Tan, Ninghan Yang, Thinesh Lee Krishnamoorthy, Vincent Oei, Alicia Chua, Xinyuan Zhao, Hui Si Tan, Adeline Chia, Nina Le Bert, Diana Low, Hiang Keat Tan, Rajneesh Kumar, Farah Gillan Irani, Zi Zong Ho, Qi Zhang, Ernesto Guccione, Lu-En Wai, Sarene Koh, William Hwang, Wan Cheng Chow, Antonio Bertoletti. Use of Expression Profiles of HBV-DNA Integrated Into Genomes of Hepatocellular Carcinoma Cells to Select T Cells for Immunotherapy. Gastroenterology 2019; 156(6) doi: 10.1053/j.gastro.2019.01.251
|
| 40 |
Ying Liu, Shengmeng Di, Bizhi Shi, Honghong Zhang, Yi Wang, Xiuqi Wu, Hong Luo, Huamao Wang, Zonghai Li, Hua Jiang. Armored Inducible Expression of IL-12 Enhances Antitumor Activity of Glypican-3–Targeted Chimeric Antigen Receptor–Engineered T Cells in Hepatocellular Carcinoma. The Journal of Immunology 2019; 203(1) doi: 10.4049/jimmunol.1800033
|
| 41 |
Iram Shahzadi, Zain Ali, Sidra Bukhari, Acharan S Narula, Bushra Mirza, Reza Mohammadinejad. Possible applications of salvianolic acid B against different cancers. Exploration of Targeted Anti-tumor Therapy 2020; 1(4) doi: 10.37349/etat.2020.00014
|
| 42 |
Hadiza Aliyu-Amoo, Hamza Ibrahim Isa, Emmanuel Mfotie Njoya, Lyndy Joy McGaw. Antiproliferative effect of extracts and fractions of the root of Terminalia avicennioides (Combretaceae) Guill and Perr. on HepG2 and Vero cell lines. Clinical Phytoscience 2021; 7(1) doi: 10.1186/s40816-021-00307-y
|
| 43 |
Ruizhen Jia, Han Xu, Chenlu Wang, Lichao Su, Jinpeng Jing, Shuyu Xu, Yu Zhou, Wenjing Sun, Jibin Song, Xiaoyuan Chen, Hongmin Chen. NIR-II emissive AIEgen photosensitizers enable ultrasensitive imaging-guided surgery and phototherapy to fully inhibit orthotopic hepatic tumors. Journal of Nanobiotechnology 2021; 19(1) doi: 10.1186/s12951-021-01168-w
|
| 44 |
Nikolaos Galanakis, Elias Kehagias, Nikolas Matthaiou, Dimitrios Samonakis, Dimitrios Tsetis. Transcatheter arterial chemoembolization combined with radiofrequency or microwave ablation for hepatocellular carcinoma: a review. Hepatic Oncology 2018; 5(2) doi: 10.2217/hep-2018-0001
|
| 45 |
Eshani J. Choksi, Mohammad Elsayed, Nima Kokabi. Antitumor Activity of Metformin Combined with Locoregional Therapy for Liver Cancer: Evidence and Future Directions. Cancers 2023; 15(18) doi: 10.3390/cancers15184538
|
| 46 |
Sharmi Mukherjee, Anindita Dutta, Anindita Chakraborty. γ-radiation-induced damage on normal hepatocytes and its protection by ethyl cinnamate. Journal of Radioanalytical and Nuclear Chemistry 2024; 333(3) doi: 10.1007/s10967-023-09067-0
|
| 47 |
Syu-ichi Kanno, Kaori Kurauchi, Ayako Tomizawa, Shin Yomogida, Masaaki Ishikawa. Pifithrin-alpha has a p53-independent cytoprotective effect on docosahexaenoic acid-induced cytotoxicity in human hepatocellular carcinoma HepG2 cells. Toxicology Letters 2015; 232(2) doi: 10.1016/j.toxlet.2014.11.016
|
| 48 |
Katie Healy, Andrea Pavesi, Tiphaine Parrot, Michał J. Sobkowiak, Susanne E. Reinsbach, Haleh Davanian, Anthony T. Tan, Soo Aleman, Johan K. Sandberg, Antonio Bertoletti, Margaret Sällberg Chen. Human MAIT cells endowed with HBV specificity are cytotoxic and migrate towards HBV-HCC while retaining antimicrobial functions. JHEP Reports 2021; 3(4) doi: 10.1016/j.jhepr.2021.100318
|
| 49 |
Benyuan Deng, Min Yang, Ming Wang, Zhongwu Liu. Development and validation of 9-long Non-coding RNA signature to predicting survival in hepatocellular carcinoma. Medicine 2020; 99(21) doi: 10.1097/MD.0000000000020422
|
| 50 |
Jingyang Xu, Hongbo Chang, Yongzhao Wang, Yi Du, Liping Zhong, Hongjuan Cui. Kuwanon A Targeted YWHAB in Hepatocellular Carcinoma Cells to Inhibit the Raf/MEK/ERK Signaling Pathway. Cells 2025; 14(19) doi: 10.3390/cells14191487
|
| 51 |
Akhilendra Kumar Maurya, Manjula Vinayak. Anticarcinogenic action of quercetin by downregulation of phosphatidylinositol 3-kinase (PI3K) and protein kinase C (PKC) via induction of p53 in hepatocellular carcinoma (HepG2) cell line. Molecular Biology Reports 2015; 42(9) doi: 10.1007/s11033-015-3921-7
|
| 52 |
Kalaivani Buskaran, Mohd Zobir Hussein, Mohamad Aris Mohd Moklas, Mas Jaffri Masarudin, Sharida Fakurazi. Graphene Oxide Loaded with Protocatechuic Acid and Chlorogenic Acid Dual Drug Nanodelivery System for Human Hepatocellular Carcinoma Therapeutic Application. International Journal of Molecular Sciences 2021; 22(11) doi: 10.3390/ijms22115786
|
| 53 |
Michelle Kozeniecki, Rachel Ludke, Jennifer Kerner, Brittney Patterson. Micronutrients in Liver Disease: Roles, Risk Factors for Deficiency, and Recommendations for Supplementation. Nutrition in Clinical Practice 2020; 35(1) doi: 10.1002/ncp.10451
|
| 54 |
Johanna K. DiStefano. Long noncoding RNAs in the initiation, progression, and metastasis of hepatocellular carcinoma. Non-coding RNA Research 2017; 2(3-4) doi: 10.1016/j.ncrna.2017.11.001
|
| 55 |
Hang Song, Yan Liu, Xinquan Li, Shuhua Chen, Rongzhang Xie, Dabao Chen, Huawu Gao, Guoquan Wang, Biao Cai, Xiangyu Yang. Long noncoding RNA CASC11 promotes hepatocarcinogenesis and HCC progression through EIF4A3‐mediated E2F1 activation. Clinical and Translational Medicine 2020; 10(7) doi: 10.1002/ctm2.220
|
| 56 |
Takashi Ota, Atsushi Nakamoto, Hiromitsu Onishi, Takahiro Tsuboyama, Shohei Matsumoto, Hideyuki Fukui, Koki Kaketaka, Toru Honda, Kengo Kiso, Mitsuaki Tatsumi, Noriyuki Tomiyama. Low-KeV Virtual Monoenergetic Dual-Energy CT with Deep Learning Reconstruction for Assessing Hepatocellular Carcinoma. Journal of Medical and Biological Engineering 2024; 44(2) doi: 10.1007/s40846-024-00855-x
|
| 57 |
Nkosiyethu K. Mkhwanazi, Charles B. de Koning, Willem A.L. van Otterlo, Mario Ariatti, Moganavelli Singh. PEGylation potentiates hepatoma cell targeted liposome-mediated in vitro gene delivery via the asialoglycoprotein receptor. Zeitschrift für Naturforschung C 2017; 72(7-8) doi: 10.1515/znc-2016-0172
|
| 58 |
Erika Araujo, Ian M. Bell, Alexander Burckle, Dennis C. Koester, James R. Manning, Richard D. Caldwell, Georgette Castanedo, Samantha A. Green, Mingshuo Zeng, Laurent Debien, T. G. Murali Dhar, Natalie Holmberg-Douglas, Eric R. Welin, J. Robert Merritt, Kevin M. Peese, Denise C. Grünenfelder, Julian C. Lo. 2022 Medicinal Chemistry Reviews. Medicinal Chemistry Reviews 2022; 57 doi: 10.1021/mc-2022-vol57.ch24
|
| 59 |
Kuo-Shyang Jeng, Ssu-Jung Lu, Chih-Hsuan Wang, Chiung-Fang Chang. Liver Fibrosis and Inflammation under the Control of ERK2. International Journal of Molecular Sciences 2020; 21(11) doi: 10.3390/ijms21113796
|
| 60 |
Kishor Pant, Anoop Saraya, Senthil K. Venugopal. Oxidative stress plays a key role in butyrate-mediated autophagy via Akt/mTOR pathway in hepatoma cells. Chemico-Biological Interactions 2017; 273 doi: 10.1016/j.cbi.2017.06.001
|
| 61 |
Velery Virgina Putri Wibowo, Zuherman Rustam, Sri Hartini, Qisthina Syifa Setiawan, Jane Eva Aurelia. Comparison between Support Vector Machine and Random Forest for Hepatocellular Carcinoma (HCC) Classification. 2020 International Conference on Decision Aid Sciences and Application (DASA) 2020; doi: 10.1109/DASA51403.2020.9317083
|
| 62 |
Tommaso Vincenzo Bartolotta, Adele Taibbi, Domenica Matranga, Massimo Midiri, Roberto Lagalla. 3D versus 2D contrast-enhanced sonography in the evaluation of therapeutic response of hepatocellular carcinoma after locoregional therapies: preliminary findings. La radiologia medica 2015; 120(8) doi: 10.1007/s11547-015-0514-4
|
| 63 |
Ming-Xu Qiao, Chun Li, Ai-Qun Zhang, Ling-Ling Hou, Juan Yang, Hong-Gang Hu. Regulation of DEK expression by AP-2α and methylation level of DEK promoter in hepatocellular carcinoma. Oncology Reports 2016; 36(4) doi: 10.3892/or.2016.4984
|
| 64 |
Ji Eun Kim, Jeong Min Lee, Dong Ho Lee, Won Chang, Jeong Hee Yoon, Joon Goo Han. Clinical Utility of Liver Stiffness Measurements on Magnetic Resonance Elastrography in Patients with Hepatocellular Carcinoma Treated with Radiofrequency Ablation. Investigative Magnetic Resonance Imaging 2016; 20(4) doi: 10.13104/imri.2016.20.4.231
|
| 65 |
Jennifer Pursley, Issam El Naqa, Nina N. Sanford, Bridget Noe, Jennifer Y. Wo, Christine E. Eyler, Matthew Hwang, Kristy K. Brock, Beow Y. Yeap, John A. Wolfgang, Theodore S. Hong, Clemens Grassberger. Dosimetric Analysis and Normal-Tissue Complication Probability Modeling of Child-Pugh Score and Albumin-Bilirubin Grade Increase After Hepatic Irradiation. International Journal of Radiation Oncology*Biology*Physics 2020; 107(5) doi: 10.1016/j.ijrobp.2020.04.027
|
| 66 |
Vellavalapalli Satish, Ramjee Repaka. The influence of microwave ablation parameters on the positioning of trocar in different cancerous tissues: a numerical study. Electromagnetic Biology and Medicine 2024; 43(1-2) doi: 10.1080/15368378.2024.2333802
|
| 67 |
Xiangyu Yang, Hang Song, Zhenguo Zi, Jiantao Kou, Shuhua Chen, Yang Dai, Jiangfeng Wang, Liudi Yuan, Kun Gao. Circ_0005075 promotes hepatocellular carcinoma progression by suppression of microRNA‐335. Journal of Cellular Physiology 2019; 234(12) doi: 10.1002/jcp.28757
|
| 68 |
Gorkem Odabas, Metin Cetin, Serdar Turhal, Huseyin Baloglu, A. Emre Sayan, Tamer Yagci. Plexin C1 Marks Liver Cancer Cells with Epithelial Phenotype and Is Overexpressed in Hepatocellular Carcinoma. Canadian Journal of Gastroenterology and Hepatology 2018; 2018 doi: 10.1155/2018/4040787
|
| 69 |
Neng Tang, Xiaolin Dou, Xing You, Yixiong Li, Xi Li, Guodong Liu. Androgen Receptors Act as a Tumor Suppressor Gene to Suppress Hepatocellular Carcinoma Cells Progression via miR-122-5p/RABL6 Signaling. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.756779
|
| 70 |
Xue Yang, Bowen Yao, Yongshen Niu, Tianxiang Chen, Huanye Mo, Liang Wang, Cheng Guo, Demao Yao. Hypoxia-induced lncRNA EIF3J-AS1 accelerates hepatocellular carcinoma progression via targeting miR-122–5p/CTNND2 axis. Biochemical and Biophysical Research Communications 2019; 518(2) doi: 10.1016/j.bbrc.2019.08.039
|
| 71 |
Nidhi Sharma, Subhrajit Biswas, Noura Al-Dayan, Alaa Saud Alhegaili, Maryam Sarwat. Antioxidant Role of Kaempferol in Prevention of Hepatocellular Carcinoma. Antioxidants 2021; 10(9) doi: 10.3390/antiox10091419
|
| 72 |
Andrew Tran, John T. Moon, Jamil Shaikh, Nariman Nezami. Acetazolamide enhanced drug-eluting beads: manipulating the hepatocellular carcinoma microenvironment. Minimally Invasive Therapy & Allied Technologies 2022; 31(6) doi: 10.1080/13645706.2022.2040535
|
| 73 |
Pelin BALÇIK ERÇİN. Integrative Analysis of SIX1 and Cancer Stem Cell Markers in Hepatocellular Carcinoma. Celal Bayar Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi 2020; 7(3) doi: 10.34087/cbusbed.689797
|
| 74 |
Sikhumbuzo Charles Kunene, Kuen-Song Lin, Meng-Tzu Weng, Maria Janina Carrera Espinoza, You-Sheng Lin, Chun-Ming Wu, Wei-Chin Tsai. Dual stimuli-responsive polymeric microgels for enhanced doxorubicin delivery to hepatocellular carcinoma. Journal of Drug Delivery Science and Technology 2023; 87 doi: 10.1016/j.jddst.2023.104776
|
| 75 |
Xuee Luo, Ning Zhou, Le Wang, Qinghua Zeng, Hongying Tang. Long Noncoding RNA GATA3-AS1 Promotes Cell Proliferation and Metastasis in Hepatocellular Carcinoma by Suppression of PTEN, CDKN1A, and TP53. Canadian Journal of Gastroenterology and Hepatology 2019; 2019 doi: 10.1155/2019/1389653
|
| 76 |
Dalia W. Zidan, Wafaa S. Hassan, Manal S. ElMasry, Abdalla A. Shalaby. Novel spectrophotometric and factor-based multivariate calibration-prediction techniques for determination of two inhibitors of hepatitis C-virus and hepatocellular carcinoma in pure, human urine, and human plasma. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 2019; 213 doi: 10.1016/j.saa.2018.12.052
|
| 77 |
Yanyan Zheng, Zheng Lu, Jiage Ding, Nan Jiang, Jiawei Wang, Jie Yang, Jingyuan Song, Hongliang Chen, Lin Fang, Huizhong Li, Hui Tian, Gang Wang, Junnian Zheng, Dafei Chai. Therapeutic Adenovirus Vaccine Combined Immunization with IL-12 Induces Potent CD8+ T Cell Anti-Tumor Immunity in Hepatocellular Carcinoma. Cancers 2022; 14(18) doi: 10.3390/cancers14184512
|
| 78 |
Xiaoguang Liu, Lixing Chen, Yuying Li, Chuanchuan He, Xiaojuan Zhang, Huimin Zhou, Guangfa Bao, Xiaohua Zhu, Guangya Xiang, Xiang Ma. Synthesis of novel DOTA-/AAZTA-based bifunctional chelators: Solution thermodynamics, peptidomimetic conjugation, and radiopharmaceutical evaluation. Biomedicine & Pharmacotherapy 2023; 165 doi: 10.1016/j.biopha.2023.115114
|
| 79 |
|
| 80 |
Hoàng Long Võ, Chí Linh Trần, Thị Kim Ngân Nguyễn, Nguyễn Kim Ngân Trần, Hữu Thoại Nguyễn, Hoàng Duy Tô, Thị Xuân Trang Đái. Khảo sát khả năng kháng oxy hóa và đối kháng sinh học của vi khuẩn nội sinh phân lập từ cây mắc cỡ tàn dù (Biophytum sensitivum L.) . CTU Journal of Science 2024; 60 doi: 10.22144/ctujos.2024.362
|
| 81 |
Xiang-Jun Han, Hong-Ying Su, Hai-Bo Shao, Ke Xu. Prognostic factors of spontaneously ruptured hepatocellular carcinoma. World Journal of Gastroenterology 2015; 21(24): 7488-7494 doi: 10.3748/wjg.v21.i24.7488
|
| 82 |
Philipp M. Kazmierczak, Daniel Theisen, Kolja M. Thierfelder, Wieland H. Sommer, Maximilian F. Reiser, Mike Notohamiprodjo, Konstantin Nikolaou. Improved Detection of Hypervascular Liver Lesions With CAIPIRINHA–Dixon–TWIST–Volume-Interpolated Breath-Hold Examination. Investigative Radiology 2015; 50(3) doi: 10.1097/RLI.0000000000000118
|
| 83 |
Xilu Liu, Yujuan Shao, Penghui Lv, Long Zhang. Superparamagnetic Iron Oxide Nanoparticles (SPIONs) Loaded with miR-29a Improve Efficacy of Chemotherapy in Hepatocellular Carcinoma. Science of Advanced Materials 2021; 13(11) doi: 10.1166/sam.2021.4096
|
| 84 |
Spencer J. Cheng, Aasthaa Bansal, David L. Veenstra. Productivity loss by cancer stage in patients newly diagnosed with hepatocellular carcinoma: A claims database analysis. Journal of Managed Care & Specialty Pharmacy 2024; 30(6) doi: 10.18553/jmcp.2024.30.6.572
|
| 85 |
B. Hasturk, T. Avsar, S. Ozbas, B. Karademir Yilmaz, F. Eren. N-Acetylgalactosamine-Conjugated Antisense Oligonucleotides Designed as Inhibitors of ABCB1: Coping with Multidrug Resistance in Hepatocellular Carcinoma. Molecular Biology 2024; 58(6) doi: 10.1134/S0026893324060050
|
| 86 |
Dinh-Chuong Pham, Hoang-Chinh Nguyen, Thanh-Hang Le Nguyen, Hoang-Linh Ho, Thien-Kim Trinh, Jirawat Riyaphan, Ching-Feng Weng, Ali Nokhodchi. Optimization of Ultrasound‐Assisted Extraction of Flavonoids from Celastrus hindsii Leaves Using Response Surface Methodology and Evaluation of Their Antioxidant and Antitumor Activities. BioMed Research International 2020; 2020(1) doi: 10.1155/2020/3497107
|
| 87 |
Riccardo Muglia, Paolo Marra, Domenico Pinelli, Ludovico Dulcetta, Francesco Saverio Carbone, Alessandro Barbaro, Antonio Celestino, Michele Colledan, Sandro Sironi. Technical and Clinical Outcomes of Laparoscopic–Laparotomic Hepatocellular Carcinoma Thermal Ablation with Microwave Technology: Case Series and Review of Literature. Cancers 2023; 16(1) doi: 10.3390/cancers16010092
|
| 88 |
Jia Yan, Ming Shu, Xiang Li, Hua Yu, Shuhuai Chen, Shujie Xie. Prognostic Score-based Clinical Factors and Metabolism-related Biomarkers for Predicting the Progression of Hepatocellular Carcinoma. Evolutionary Bioinformatics 2020; 16 doi: 10.1177/1176934320951571
|
| 89 |
Yong Sun, Rong Tsao, Fang Chen, Hongyan Li, Han Peng, Li Jiang, Yuhuan Chen, Zeyuan Deng. The phenolic profiles of Radix Tetrastigma after solid phase extraction (SPE) and their antitumor effects and antioxidant activities in H22 tumor-bearing mice. Food & Function 2017; 8(11) doi: 10.1039/C7FO00769H
|
| 90 |
Mafei Kang, Feng Xue, Shengyuan Xu, Jieqiong Shi, Yunyan Mo. Effectiveness and safety of anlotinib with or without S-1 in the treatment of patients with advanced hepatocellular carcinoma in a Chinese population: a prospective, phase 2 study. Radiology and Oncology 2023; 57(3) doi: 10.2478/raon-2023-0036
|
| 91 |
Chinmay Das, Chanakya Nath Kundu. Decoding the molecular complexity of viruses in human cancer: insights into host cell infection, oncogenesis, and therapeutic prospects. Critical Reviews in Microbiology 2025; 51(6) doi: 10.1080/1040841X.2025.2461045
|
| 92 |
Lydia Renardson, Hassaan Bari, Jawad Ahmad. Can focal nodular hyperplasia transform into hepatocellular carcinoma? A 20-year journey from benign to malignant. BMJ Case Reports 2026; 19(7) doi: 10.1136/bcr-2025-270444
|
| 93 |
Gonzalo Sapisochin, Elena Fernandez de Sevilla, Juan Echeverri, Ramón Charco. Management of “very early” hepatocellular carcinoma on cirrhotic patients. World Journal of Hepatology 2014; 6(11): 766-775 doi: 10.4254/wjh.v6.i11.766
|
| 94 |
Joseph H. Yacoub, Christine C. Hsu, Thomas M. Fishbein, David Mauro, Andrew Moon, Aiwu R. He, Mustafa R. Bashir, Lauren M. B. Burke. Therapies for hepatocellular carcinoma: overview, clinical indications, and comparative outcome evaluation—part one: curative intention. Abdominal Radiology 2021; 46(8) doi: 10.1007/s00261-021-03069-w
|
| 95 |
Dipika Mandal, Tapan Kumar Shaw, Goutam Dey, Murari Mohan Pal, Biswajit Mukherjee, Amal Kumar Bandyopadhyay, Mahitosh Mandal. Preferential hepatic uptake of paclitaxel-loaded poly-(d-l-lactide-co-glycolide) nanoparticles — A possibility for hepatic drug targeting: Pharmacokinetics and biodistribution. International Journal of Biological Macromolecules 2018; 112 doi: 10.1016/j.ijbiomac.2018.02.021
|
| 96 |
Weifeng Tan, Jingquan He, Junliang Deng, Xinwei Yang, Longjiu Cui, Rongzheng Ran, Guangwei Du, Xiaoqing Jiang. Small molecule metabolite biomarkers for hepatocellular carcinoma with bile duct tumor thrombus diagnosis. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-21595-4
|
| 97 |
Reina Sasaki, Tatsuo Kanda, Osamu Yokosuka, Naoya Kato, Shunichi Matsuoka, Mitsuhiko Moriyama. Exosomes and Hepatocellular Carcinoma: From Bench to Bedside. International Journal of Molecular Sciences 2019; 20(6) doi: 10.3390/ijms20061406
|
| 98 |
Enayatollah Seydi, Zahra Rahimpour, Ahmad Salimi, Jalal Pourahmad. Selective toxicity of chrysin on mitochondria isolated from liver of a HCC rat model. Bioorganic & Medicinal Chemistry 2019; 27(24) doi: 10.1016/j.bmc.2019.115163
|
| 99 |
Michela Anna Polidoro, Joanna Mikulak, Valentina Cazzetta, Ana Lleo, Domenico Mavilio, Guido Torzilli, Matteo Donadon. Tumor microenvironment in primary liver tumors: A challenging role of natural killer cells. World Journal of Gastroenterology 2020; 26(33): 4900-4918 doi: 10.3748/wjg.v26.i33.4900
|
| 100 |
Tong-Hong Wang, Chi-Hao Wu, Chau-Ting Yeh, Shih-Chi Su, Shih-Min Hsia, Kung-Hao Liang, Chin-Chuan Chen, Chuen Hsueh, Chi-Yuan Chen. Melatonin suppresses hepatocellular carcinoma progression via lncRNA-CPS1-IT-mediated HIF-1α inactivation. Oncotarget 2017; 8(47) doi: 10.18632/oncotarget.19316
|
| 101 |
Yi-Hsuan Hung, Yu-Chuan Lin, Yu-Ting Lin, Guan-Wen Shih, Jiunn-Wang Liao, Kuan-Sheng Chen, Hong-Ming Liu, Yi-Wei Chen, Yung-Jen Chuang, Chia-Min Yang, Jinn-Jer Peir, Chin-Hua Yang, Fong-In Chou. Suitability of boric acid as a boron drug for boron neutron capture therapy for hepatoma. Applied Radiation and Isotopes 2020; 164 doi: 10.1016/j.apradiso.2020.109254
|
| 102 |
Joshua P. Kronenfeld, Neha Goel. ASO Author Reflections: Access to Care and Screening Inequities for Patients At Risk for Hepatocellular Carcinoma. Annals of Surgical Oncology 2021; 28(4) doi: 10.1245/s10434-020-09172-4
|
| 103 |
Ruifang Wang, Xiaobo Hu, Xiaorui Liu, Lu Bai, Junsheng Gu, Qinggang Li, Edwin Wang. Construction of liver hepatocellular carcinoma-specific lncRNA-miRNA-mRNA network based on bioinformatics analysis. PLOS ONE 2021; 16(4) doi: 10.1371/journal.pone.0249881
|
| 104 |
Yan Zhao, Huina Wu, Xiaoyan Xing, Yuqian Ma, Shengping Ji, Xinyue Xu, Xin Zhao, Sensen Wang, Wenyan Jiang, Chunyan Fang, Lei Zhang, Fang Yan, Xuejian Wang. CD13 Induces Autophagy to Promote Hepatocellular Carcinoma Cell Chemoresistance Through the P38/Hsp27/CREB/ATG7 Pathway. The Journal of Pharmacology and Experimental Therapeutics 2020; 374(3) doi: 10.1124/jpet.120.265637
|
| 105 |
Shuai Zhang, Zhi‐Mei Cheng, Jia‐LI Yu, Kai Lu, Sheng‐Jie Xu, Yuan Lu, Ting Liu, Bai‐Juan Xia, Zhi Huang, Xu‐Ya Zhao, Wei He, Jun‐Xiang Li, Wei Cao, Yu Huang, Ling Wang, Zhu Zeng, Xun Zou, Rong Liu, Yu‐Sui Zhang, Xiao‐Ping Wu, Tian‐Peng Jiang, Shi Zhou. Malic enzyme 2 promotes the progression of hepatocellular carcinoma via increasing triglyceride production. Cancer Medicine 2021; 10(19) doi: 10.1002/cam4.4209
|
| 106 |
Jendrik Becker-Assmann, Mohammad H. Fard-Aghaie, Alexandros Kantas, Georgios Makridis, Tim Reese, Kim C. Wagner, Jörg Petersen, Peter Buggisch, Axel Stang, Thomas von Hahn, Karl J. Oldhafer. Diagnostische und prognostische Bedeutung des α-Feto-Proteins beim hepatozellulären Karzinom. Der Chirurg 2020; 91(9) doi: 10.1007/s00104-020-01118-6
|
| 107 |
Shu-Cai Xie, Jian-Quan Zhang, Xi-Li Jiang, Yong-Yong Hua, Shao-Wei Xie, Ye-Ang Qin, Yi-Jun Yang. LncRNA CRNDE facilitates epigenetic suppression of CELF2 and LATS2 to promote proliferation, migration and chemoresistance in hepatocellular carcinoma. Cell Death & Disease 2020; 11(8) doi: 10.1038/s41419-020-02853-8
|
| 108 |
Xiaotao Zhang, Hashem B. El-Serag, Aaron P. Thrift. Predictors of five-year survival among patients with hepatocellular carcinoma in the United States: an analysis of SEER-Medicare. Cancer Causes & Control 2021; 32(4) doi: 10.1007/s10552-020-01386-x
|
| 109 |
Prashant Nagpal, Mitesh Bhalala, Aditi Vidholia, Rahul Sao, Nisha Sharma, Dhruv Mehta, Sam McCabe, Roxana Bodin. Abdominal Skin Rash After TACE Due to Non-Target Embolization of Hepatic Falciform Artery. ACG Case Reports Journal 2016; 3(1) doi: 10.14309/crj.2016.55
|
| 110 |
Hasibe Vural, Pınar Özden, Ebru Avcı. Ginnalin A and SB203580 show additive effect on Hep-3B hepatocellular carcinoma cell line. Turkish Journal of Biochemistry 2019; 44(1) doi: 10.1515/tjb-2018-0099
|
| 111 |
Lin He, Xuefei Cai, Shengtao Cheng, Hongzhong Zhou, Zhenzhen Zhang, Jihua Ren, Fang Ren, Qiuxia Yang, Nana Tao, Juan Chen. Ornithine transcarbamylase downregulation is associated with poor prognosis in hepatocellular carcinoma. Oncology Letters 2019; doi: 10.3892/ol.2019.10174
|
| 112 |
KN Lokesh, Tamojit Chaudhuri, KC Lakshmaiah, KGovind Babu, Lokanatha Dasappa, LinuAbraham Jacob, MC Suresh Babu, AH Rudresha, LK Rajeev. Advanced hepatocellular carcinoma: A regional cancer center experience of 48 cases. Indian Journal of Cancer 2017; 54(3) doi: 10.4103/ijc.IJC_373_17
|
| 113 |
Xuanzhi Yan, Jiaxing Fan, Wanying Qin, Minjun Liao, Siming Li, Liya Suo, Yujin Xie, Xin Jiang, Dengfeng Zou, Weijia Liao. Hypericin Nanoparticles-Associated Photodynamic Therapy Modulates the Biological Behavior of Hepatocellular Carcinoma by SERPINE1. International Journal of Nanomedicine 2025; doi: 10.2147/IJN.S507037
|
| 114 |
Ayse Banu Demir, Elif Baris, Umay Bengi Kaner, Hani Alotaibi, Nese Atabey, Ahmet Koc. Toll-interacting protein may affect doxorubicin resistance in hepatocellular carcinoma cell lines. Molecular Biology Reports 2023; 50(10) doi: 10.1007/s11033-023-08737-2
|
| 115 |
Hui-Ying Liu, Hai-Hua Qian, Xiao-Feng Zhang, Jun Li, Xia Yang, Bin Sun, Jun-Yong Ma, Lei Chen, Zheng-Feng Yin. Improved method increases sensitivity for circulating hepatocellular carcinoma cells. World Journal of Gastroenterology 2015; 21(10): 2918-2925 doi: 10.3748/wjg.v21.i10.2918
|
| 116 |
Gab Jin Cheon, Ki Hyun Kim, Jun Yeon Park, Dahae Lee, Hyuk‐Jai Jang, Jin Ho Kwak, Kun Moo Choi, Ji Hoon Kim, Gwi Seo Hwang, Jungyeob Ham, Sanghyun Lee, Dae‐Woon Eom, Ki Sung Kang. Caspase‐mediated Apoptotic Effects of Diol‐type Ginseng Sapogenins on Human Hepatoma Cell Lines. Bulletin of the Korean Chemical Society 2015; 36(1) doi: 10.1002/bkcs.10074
|
| 117 |
Yadi Liao, Yun Zheng, Wei He, Qijiong Li, Jingxian Shen, Jian Hong, Ruhai Zou, Jiliang Qiu, Binkui Li, Yunfei Yuan. Sorafenib therapy following resection prolongs disease-free survival in patients with advanced hepatocellular carcinoma at a high risk of recurrence. Oncology Letters 2017; 13(2) doi: 10.3892/ol.2016.5525
|
| 118 |
Fengdan Ye, Dongya Jia, Mingyang Lu, Herbert Levine, Michael W. Deem. Modularity of the metabolic gene network as a prognostic biomarker for hepatocellular carcinoma. Oncotarget 2018; 9(19) doi: 10.18632/oncotarget.24551
|
| 119 |
Noriho Iida, Eishiro Mizukoshi, Shuichi Kaneko. Gene Therapy and Cell Therapy Through the Liver. 2016; doi: 10.1007/978-4-431-55666-4_5
|
| 120 |
Zhi-di Li, Yang-ling Li, Jing Lu, Shang Liang, Chong Zhang, Ling-hui Zeng. Recent research progress of circular RNAs in hepatocellular carcinoma. Frontiers in Oncology 2024; 13 doi: 10.3389/fonc.2023.1192386
|
| 121 |
Hamzah Adwan, Thomas J. Vogl, Ümniye Balaban, Nour-Eldin Abdelrehim Nour-Eldin. Percutaneous Thermal Ablation Therapy of Hepatocellular Carcinoma (HCC): Microwave Ablation (MWA) versus Laser-Induced Thermotherapy (LITT). Diagnostics 2022; 12(3) doi: 10.3390/diagnostics12030564
|
| 122 |
Vincenza Granata, Roberta Fusco, Sergio Venanzio Setola, Carmine Picone, Paolo Vallone, Andrea Belli, Paola Incollingo, Vittorio Albino, Fabiana Tatangelo, Francesco Izzo, Antonella Petrillo. Microvascular invasion and grading in hepatocellular carcinoma: correlation with major and ancillary features according to LIRADS. Abdominal Radiology 2019; 44(8) doi: 10.1007/s00261-019-02056-6
|
| 123 |
Mohammad Nurul Amin, Shafayet Ahmed Siddiqui, Md Ibrahim, Md Lukman Hakim, Md. Salim Ahammed, Asma Kabir, Farhana Sultana. Inflammatory cytokines in the pathogenesis of cardiovascular disease and cancer. SAGE Open Medicine 2020; 8 doi: 10.1177/2050312120965752
|
| 124 |
Zhiwei Ye, Jing Zhao, Dandan Hu, Zhoutian Yang, Jinbin Chen, Li Xu, Zhongguo Zhou, Minshan Chen, Yaojun Zhang. Gd-EOB-DTPA-enhanced MRI proves advantageous in selecting surgical candidates for patients with early-stage hepatocellular carcinoma: An analysis in terms of oncological outcomes. iLIVER 2024; 3(4) doi: 10.1016/j.iliver.2024.100117
|
| 125 |
Laura Guerrero, Bruno Sangro, Verónica Ambao, José Ignacio Granero, Antonio Ramos-Fernández, Alberto Paradela, Fernando J. Corrales. Monitoring one-carbon metabolism by mass spectrometry to assess liver function and disease. Journal of Physiology and Biochemistry 2022; 78(1) doi: 10.1007/s13105-021-00856-3
|
| 126 |
Petra Grbčić, Elitza Petkova Markova Car, Mirela Sedić. Targeting Ceramide Metabolism in Hepatocellular Carcinoma: New Points for Therapeutic Intervention. Current Medicinal Chemistry 2020; 27(39) doi: 10.2174/0929867326666190911115722
|
| 127 |
Akanksha Dubey, Jayanthi Sivaraman. Comparative Therapeutic Approaches for Hepatocellular Carcinoma-A Concise Review. Research Journal of Pharmacy and Technology 2023; doi: 10.52711/0974-360X.2023.00726
|
| 128 |
Alba Herrero, Elisabeth Knetemann, Inge Mannaerts. Review: Challenges of In Vitro CAF Modelling in Liver Cancers. Cancers 2021; 13(23) doi: 10.3390/cancers13235914
|
| 129 |
Sanchari Roy, Christian Trautwein, Tom Luedde, Christoph Roderburg. A General Overview on Non-coding RNA-Based Diagnostic and Therapeutic Approaches for Liver Diseases. Frontiers in Pharmacology 2018; 9 doi: 10.3389/fphar.2018.00805
|
| 130 |
Hongming Pan, Zhanggui Wang, Liming Jiang, Xinbing Sui, Liangkun You, Jiawei Shou, Zhao Jing, Jiansheng Xie, Weiting Ge, Xiujun Cai, Wendong Huang, Weidong Han. Autophagy inhibition sensitizes hepatocellular carcinoma to the multikinase inhibitor linifanib. Scientific Reports 2014; 4(1) doi: 10.1038/srep06683
|
| 131 |
Dan-Yun Ruan, Ze-Xiao Lin, Yang Li, Nan Jiang, Xing Li, Dong-Hao Wu, Tian-Tian Wang, Jie Chen, Qu Lin, Xiang-Yuan Wu. Poor oncologic outcomes of hepatocellular carcinoma patients with intra-abdominal infection after hepatectomy. World Journal of Gastroenterology 2015; 21(18): 5598-5606 doi: 10.3748/wjg.v21.i18.5598
|
| 132 |
Edgar Del Carpio, Lino Hernández, Carlos Ciangherotti, Valentina Villalobos Coa, Lissette Jiménez, Vito Lubes, Giuseppe Lubes. Vanadium: History, chemistry, interactions with α-amino acids and potential therapeutic applications. Coordination Chemistry Reviews 2018; 372 doi: 10.1016/j.ccr.2018.06.002
|
| 133 |
Preedia Babu Ezhuthupurakkal, Subastri Ariraman, Suyavaran Arumugam, Nithyananthan Subramaniyan, Suresh Kumar Muthuvel, Premkumar Kumpati, Bharathidasan Rajamani, Thirunavukkarasu Chinnasamy. Anticancer potential of ZnO nanoparticle-ferulic acid conjugate on Huh-7 and HepG2 cells and diethyl nitrosamine induced hepatocellular cancer on Wistar albino rat. Nanomedicine: Nanotechnology, Biology and Medicine 2018; 14(2) doi: 10.1016/j.nano.2017.11.003
|
| 134 |
Malwina Sosnowska, Marta Kutwin, Piotr Koczoń, André Chwalibog, Ewa Sawosz. Polyhydroxylated Fullerene C60(OH)40 Nanofilms Promote the Mesenchymal–Epithelial Transition of Human Liver Cancer Cells via the TGF-β1/Smad Pathway. Journal of Inflammation Research 2023; doi: 10.2147/JIR.S415378
|
| 135 |
Peng Wu, Xiaoyong Wang, Min Yin, Wenjie Zhu, Zheng Chen, Yang Zhang, Ziyu Jiang, Longqing Shi, Qiang Zhu. ULK1 Mediated Autophagy-Promoting Effects of Rutin-Loaded Chitosan Nanoparticles Contribute to the Activation of NF-κB Signaling Besides Inhibiting EMT in Hep3B Hepatoma Cells. International Journal of Nanomedicine 2024; doi: 10.2147/IJN.S443117
|
| 136 |
Wenrong Liu, Ruiping Huai, Yin Zhang, Shuquan Rao, Lili xiong, Ruofan Ding, Canquan Mao, Wenqing Zhao, Tao Hao, Qingqing Huang, Zhiyun Guo. Down-regulation expression of TGFB2-AS1 inhibits the proliferation, migration, invasion and induces apoptosis in HepG2 cells. Genes & Genomics 2019; 41(8) doi: 10.1007/s13258-019-00826-6
|
| 137 |
Marco Di Paola, Alessandra Quarta, Francesco Conversano, Enzo Antonio Sbenaglia, Simona Bettini, Ludovico Valli, Giuseppe Gigli, Sergio Casciaro. Human Hepatocarcinoma Cell Targeting by Glypican-3 Ligand Peptide Functionalized Silica Nanoparticles: Implications for Ultrasound Molecular Imaging. Langmuir 2017; 33(18) doi: 10.1021/acs.langmuir.7b00327
|
| 138 |
Theodore J. Wigle, Elena V. Tsvetkova, Stephen A. Welch, Richard B. Kim. DPYD and Fluorouracil-Based Chemotherapy: Mini Review and Case Report. Pharmaceutics 2019; 11(5) doi: 10.3390/pharmaceutics11050199
|
| 139 |
Silvia Ribback, Verena Sailer, Enrico Böhning, Julia Günther, Jaqueline Merz, Frauke Steinmüller, Kirsten Utpatel, Antonio Cigliano, Kristin Peters, Maria Pilo, Matthias Evert, Diego Calvisi, Frank Dombrowski. The Epidermal Growth Factor Receptor (EGFR) Inhibitor Gefitinib Reduces but Does Not Prevent Tumorigenesis in Chemical and Hormonal Induced Hepatocarcinogenesis Rat Models. International Journal of Molecular Sciences 2016; 17(10) doi: 10.3390/ijms17101618
|
| 140 |
Sonia Simón Serrano, Michele Tavecchio, Alvar Grönberg, Wondossen Sime, Mohamed Jemaà, Steven Moss, Matthew Alan Gregory, Philippe Gallay, Eskil Elmér, Magnus Joakim Hansson, Ramin Massoumi. Novel Cyclophilin Inhibitor Decreases Cell Proliferation and Tumor Growth in Models of Hepatocellular Carcinoma. Cancers 2021; 13(12) doi: 10.3390/cancers13123041
|
| 141 |
Xueran Chen, Shangrong Zhang, Zhen Wang, Fengsong Wang, Xinwang Cao, Quan Wu, Chenggang Zhao, Huihui Ma, Fang Ye, Hongzhi Wang, Zhiyou Fang. Supervillin promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma in hypoxia via activation of the RhoA/ROCK-ERK/p38 pathway. Journal of Experimental & Clinical Cancer Research 2018; 37(1) doi: 10.1186/s13046-018-0787-2
|
| 142 |
Selva Jeganathan, Emily Budziszewski, Peter Bielecki, Michael C. Kolios, Agata A. Exner. In situ forming implants exposed to ultrasound enhance therapeutic efficacy in subcutaneous murine tumors. Journal of Controlled Release 2020; 324 doi: 10.1016/j.jconrel.2020.05.003
|
| 143 |
Mayara Lilian Paulino Miranda, Kelly Silva Furtado, Fábia de Oliveira Andrade, Renato Heidor, Raquel Santana da Cruz, Marina Sayuri Nogueira, Inar Alves de Castro, Eduardo Purgatto, Luis Fernando Barbisan, Fernando Salvador Moreno. β-ionone inhibits nonalcoholic fatty liver disease and its association with hepatocarcinogenesis in male Wistar rats. Chemico-Biological Interactions 2019; 308 doi: 10.1016/j.cbi.2019.05.046
|
| 144 |
David E. Hinojosa‐Gonzalez, Gustavo Salgado‐Garza, Eduardo Tellez‐Garcia, Jaime A. Escarcega‐Bordagaray, Luis Carlos Bueno‐Gutierrez, Katheryne Madrazo‐Aguirre, Monica I. Muñoz‐Hibert, Karla G. Diaz‐Garza, Isabela Ramirez‐Mulhern, Rodrigo Alvarez de la Reguera‐Babb, Eduardo Flores‐Villalba, Mario Rodarte‐Shade, Mauricio Gonzalez‐Urquijo. Blood salvage and autotransfusion during orthotopic liver transplantation for hepatocellular carcinoma: A systematic review and meta‐analysis. Clinical Transplantation 2024; 38(1) doi: 10.1111/ctr.15222
|
| 145 |
Wenjie Wang, Chen Zhang, Qihong Yu, Xichuan Zheng, Chuanzheng Yin, Xueke Yan, Gang Liu, Zifang Song. Development of a novel lipid metabolism-based risk score model in hepatocellular carcinoma patients. BMC Gastroenterology 2021; 21(1) doi: 10.1186/s12876-021-01638-3
|
| 146 |
Napaporn Khuanphram, Sirinya Taya, Prachya Kongtawelert, Rawiwan Wongpoomchai. Sesame Extract Promotes Chemopreventive Effect of Hesperidin on Early Phase of Diethylnitrosamine-Initiated Hepatocarcinogenesis in Rats. Pharmaceutics 2021; 13(10) doi: 10.3390/pharmaceutics13101687
|
| 147 |
Chris Zhiyi Zhang, Evandro Fei Fang, Hai-Tao Zhang, Li-Li Liu, Jing-Ping Yun.
Momordica Charantia lectin exhibits antitumor activity towards hepatocellular carcinoma. Investigational New Drugs 2015; 33(1) doi: 10.1007/s10637-014-0156-8
|
| 148 |
Sue Anne Chew, Stefania Moscato, Sachin George, Bahareh Azimi, Serena Danti. Liver Cancer: Current and Future Trends Using Biomaterials. Cancers 2019; 11(12) doi: 10.3390/cancers11122026
|
| 149 |
Yi-Hua Zhang, Katharina Brehmer, Anders Svensson, Gunnar Herlin, Per Stål, Torkel B Brismar. Variation in textural parameters of hepatic lesions during contrast medium injection. Acta Radiologica 2021; 62(10) doi: 10.1177/0284185120964904
|
| 150 |
Tong-Hong Wang, Chuen Hsueh, Chin-Chuan Chen, Wan-Syuan Li, Chau-Ting Yeh, Jang-Hau Lian, Junn-Liang Chang, Chi-Yuan Chen. Melatonin Inhibits the Progression of Hepatocellular Carcinoma through MicroRNA Let7i-3p Mediated RAF1 Reduction. International Journal of Molecular Sciences 2018; 19(9) doi: 10.3390/ijms19092687
|
| 151 |
Hong Yang, Da Sun, Bin Zhang, Chun Yu. EGR3 Transcriptionally Upregulates the Expression of DCN in Liver Cancer to Inhibit Tumor Progression. Journal of Biochemical and Molecular Toxicology 2025; 39(7) doi: 10.1002/jbt.70399
|
| 152 |
Xuying Wan, Xiaofeng Zhai, Zhenlin Yan, Pinghua Yang, Jun Li, Dong Wu, Kui Wang, Yong Xia, Feng Shen. Retrospective analysis of transarterial chemoembolization and sorafenib in Chinese patients with unresectable and recurrent hepatocellular carcinoma. Oncotarget 2016; 7(50) doi: 10.18632/oncotarget.11514
|
| 153 |
Yuting Song, Ying Wang, Xin Geng, Xianming Wang, Huisi He, Youwen Qian, Yaping Dong, Zhecai Fan, Shuzhen Chen, Wen Wen, Hongyang Wang. Novel biomarker genes for the prediction of post-hepatectomy survival of patients with NAFLD-related hepatocellular carcinoma. Cancer Cell International 2023; 23(1) doi: 10.1186/s12935-023-03106-2
|
| 154 |
Jieun Kim, Youngmi Jung. Radiation-induced liver disease: current understanding and future perspectives. Experimental & Molecular Medicine 2017; 49(7) doi: 10.1038/emm.2017.85
|
| 155 |
Jialin Wei, Zhiyuan Sun, Li Shi, Shaodan Hu, Da Liu, Hong Wei. Molecular Mechanism of Chrysin in Hepatocellular Carcinoma Treatment Based on Network Pharmacology and in Vitro Experiments. Natural Product Communications 2021; 16(12) doi: 10.1177/1934578X211067294
|
| 156 |
Li-Cong Liang, Wen-Sou Huang, Zhao-Xiong Guo, Hong-Ji You, Yong-Jian Guo, Ming-Yue Cai, Li-Teng Lin, Guo-Ying Wang, Kang-Shun Zhu. Liver transplantation following two conversions in a patient with huge hepatocellular carcinoma and portal vein invasion: A case report. World Journal of Gastroenterology 2024; 30(36): 4071-4077 doi: 10.3748/wjg.v30.i36.4071
|
| 157 |
Sirinya Taya, Charatda Punvittayagul, Puttinan Meepowpan, Rawiwan Wongpoomchai. Cancer Chemopreventive Effect of 2′,4′-Dihydroxy-6′-methoxy-3′,5′-dimethylchalcone on Diethylnitrosamine-Induced Early Stages of Hepatocarcinogenesis in Rats. Plants 2024; 13(14) doi: 10.3390/plants13141975
|
| 158 |
Kevin Leong, Kishore Kuppasani, Nikoloas Pyrsopoulos. Atrial tumor thrombus. JAAPA 2019; 32(2) doi: 10.1097/01.JAA.0000552723.65316.80
|
| 159 |
Yucel Aydin, Ali Riza Koksal, Paul Thevenot, Srinivas Chava, Zahra Heidari, Dong Lin, Tyler Sandow, Krzysztof Moroz, Mansour A Parsi, John Scott, Ari Cohen, Srikanta Dash. Experimental Validation of Novel Glypican 3 Exosomes for the Detection of Hepatocellular Carcinoma in Liver Cirrhosis. Journal of Hepatocellular Carcinoma 2021; doi: 10.2147/JHC.S327339
|
| 160 |
Woo Jae Shin, Brian A. Zabel, Russell K. Pachynski. Mechanisms and Functions of Chemerin in Cancer: Potential Roles in Therapeutic Intervention. Frontiers in Immunology 2018; 9 doi: 10.3389/fimmu.2018.02772
|
| 161 |
Vennila Krishnan, Chitra Loganathan, Palvannan Thayumanavan. Green synthesized selenium nanoparticle as carrier and potent delivering agent of s-allyl glutathione: Anticancer effect against hepatocarcinoma cell line (HepG2) through induction of cell cycle arrest and apoptosis. Journal of Drug Delivery Science and Technology 2019; 53 doi: 10.1016/j.jddst.2019.101207
|
| 162 |
. 2019; doi: 10.70675/aaef06b8z77e8z42ccz929cz1f7b59bd4414
|
| 163 |
Ke Hu, Nian‐Feng Li, Jia‐Rong Li, Ze‐Guo Chen, Jian‐Hua Wang, Lang‐Qing Sheng. Exosome circCMTM3 promotes angiogenesis and tumorigenesis of hepatocellular carcinoma through miR‐3619‐5p/SOX9. Hepatology Research 2021; 51(11) doi: 10.1111/hepr.13692
|
| 164 |
Uyen Mui, Christopher Haley, Stephen Tyring. Viral Oncology: Molecular Biology and Pathogenesis. Journal of Clinical Medicine 2017; 6(12) doi: 10.3390/jcm6120111
|
| 165 |
KUO-SHYANG JENG, PO-YU CHENG, YUEH-HSIEN LIN, PO-CHUN LIU, PING-HUI TSENG, YU-CHAO WANG, CHIUNG-FANG CHANG, CHUEN-MIIN LEU. Aldo-keto reductase family member C3 (AKR1C3) promotes hepatocellular carcinoma cell growth by producing prostaglandin F2α. Oncology Research 2024; 32(1) doi: 10.32604/or.2023.030975
|
| 166 |
Xin Zhao, Wenpeng Liu, Baowang Liu, Qiang Zeng, Ziqiang Cui, Yang Wang, Jinglin Cao, Qingjun Gao, Caiyan Zhao, Jian Dou. Exploring the underlying molecular mechanism of liver cancer cells under hypoxia based on RNA sequencing. BMC Genomic Data 2022; 23(1) doi: 10.1186/s12863-022-01055-9
|
| 167 |
Sikhumbuzo Charles Kunene, Kuen-Song Lin, Meng-Tzu Weng, Maria Janina Carrera Espinoza, You-Sheng Lin, Yi-Ting Lin. Design of biomimetic targeting nanoclusters for enhanced doxorubicin delivery to liver cancer. European Polymer Journal 2023; 186 doi: 10.1016/j.eurpolymj.2023.111861
|
| 168 |
Michal S. Shoshan, Thomas Vonderach, Bodo Hattendorf, Helma Wennemers. Peptide‐Coated Platinum Nanoparticles with Selective Toxicity against Liver Cancer Cells. Angewandte Chemie 2019; 131(15) doi: 10.1002/ange.201813149
|
| 169 |
WenJi Lin, CongHui Zhu, JiaDi Yao, YuHuang Liu, HuiYu Lin, Yan Liu, Ashok Pandurangan. Multifactorial Analysis of Clinical Prognosis of Liver Metastasis and Vascular Intervention Combined with Ablation in Colorectal Cancer. Journal of Oncology 2022; 2022 doi: 10.1155/2022/9690401
|
| 170 |
Shiwei Liu, Fukang Yuan, Hui Dong, Jiaqi Zhang, Xinyu Mao, Yangsui Liu, Huansong Li. PTGES3 proteolysis using the liposomal peptide-PROTAC approach. Biology Direct 2024; 19(1) doi: 10.1186/s13062-024-00580-0
|
| 171 |
Alexandre Bigot, Gilles Soulez, Sylvain Martel. A prototype of injector to control and to detect the release of magnetic beads within the constraints of multibifurcation magnetic resonance navigation procedures. Magnetic Resonance in Medicine 2017; 77(1) doi: 10.1002/mrm.26109
|
| 172 |
Jaya Lakshmi Thangaraj, Michael Coffey, Edith Lopez, Dan S. Kaufman. Disruption of TGF-β signaling pathway is required to mediate effective killing of hepatocellular carcinoma by human iPSC-derived NK cells. Cell Stem Cell 2024; 31(9) doi: 10.1016/j.stem.2024.06.009
|
| 173 |
Xiaojin Li, Anjian Xu, Huihui Li, Bei Zhang, Bangwei Cao, Jian Huang. Novel role of apatinib as a multi-target RTK inhibitor in the direct suppression of hepatocellular carcinoma cells. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2018; 1864(5) doi: 10.1016/j.bbadis.2018.02.014
|
| 174 |
Maria E. Lozada, Roongruedee Chaiteerakij, Lewis R. Roberts. Screening for Hepatocellular Carcinoma and Cholangiocarcinoma: Can Biomarkers Replace Imaging?. Current Hepatology Reports 2015; 14(2) doi: 10.1007/s11901-015-0261-y
|
| 175 |
Chunye Zhang, Ming Yang, Aaron C. Ericsson. The Potential Gut Microbiota-Mediated Treatment Options for Liver Cancer. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.524205
|
| 176 |
Vijaya Nirmala Pangi. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma. 2022; doi: 10.1016/B978-0-323-98806-3.00021-0
|
| 177 |
Sommer Luu, Cary Hsu, Eric J. Silberfein. Demographic and Clinicopathologic Factors of Patients With Hepatocellular Carcinoma in a Safety Net Hospital. Journal of Surgical Research 2020; 256 doi: 10.1016/j.jss.2020.06.046
|
| 178 |
Jonathan Selzman, Mahesh Gajendran, Bara El Kurdi, Venkata Katabathina, Randy Wright, Chandraprakash Umapathy, Juan Echavarria. Transarterial Chemoembolization-Induced Ischemic Colitis: A Rare Complication Due to Nontarget Embolization. ACG Case Reports Journal 2023; 10(9) doi: 10.14309/crj.0000000000001140
|
| 179 |
Maciej Maciak, Marcin Konior, Danuta Wawszczak, Aleksandra Majewska, Klaudia Brodaczewska, Piotr Piasecki, Jerzy Narloch, Maria Sady, Jarosław Olszewski, Zdzisław Gajewski, Claudine Kieda, Tomasz Dziel, Edward Iller. Physical properties and biological impact of 90Y microspheres prepared by sol-gel method for liver radioembolization. Radiation Physics and Chemistry 2023; 202 doi: 10.1016/j.radphyschem.2022.110506
|
| 180 |
Hongzhi Wang, Satheesh Ellipilli, Wen-Jui Lee, Xin Li, Mario Vieweger, Yuan-Soon Ho, Peixuan Guo. Multivalent rubber-like RNA nanoparticles for targeted co-delivery of paclitaxel and MiRNA to silence the drug efflux transporter and liver cancer drug resistance. Journal of Controlled Release 2021; 330 doi: 10.1016/j.jconrel.2020.12.007
|
| 181 |
Ronik S. Bhangoo, Trey C. Mullikin, Jonathan B. Ashman, Tiffany W. Cheng, Michael A. Golafshar, Todd A. DeWees, Jedediah E. Johnson, Satomi Shiraishi, Wei Liu, Yanle Hu, Kenneth W. Merrell, Michael G. Haddock, Sunil Krishnan, William G. Rule, Terence T. Sio, Christopher L. Hallemeier. Intensity Modulated Proton Therapy for Hepatocellular Carcinoma: Initial Clinical Experience. Advances in Radiation Oncology 2021; 6(4) doi: 10.1016/j.adro.2021.100675
|
| 182 |
Biki Saha, Sneha Pallatt, Antara Banerjee, Abhijit G. Banerjee, Rupak Pathak, Surajit Pathak. Current Insights into Molecular Mechanisms and Potential Biomarkers for Treating Radiation-Induced Liver Damage. Cells 2024; 13(18) doi: 10.3390/cells13181560
|
| 183 |
Dafina Janevska, Viktorija Chaloska-Ivanova, Vlado Janevski. Hepatocellular Carcinoma: Risk Factors, Diagnosis and Treatment. Open Access Macedonian Journal of Medical Sciences 2015; 3(4) doi: 10.3889/oamjms.2015.111
|
| 184 |
Abdalla Aly, Melissa Lingohr-Smith, Jay Lin, Brian Seal. Locoregional therapy patterns and healthcare economic burden of patients with hepatocellular carcinoma in the USA. Hepatic Oncology 2021; 8(3) doi: 10.2217/hep-2021-0001
|
| 185 |
Yanqing Feng, Gang Wei, Linfei Zhang, Huadong Zhou, Wei Wang, Peng Guo, Caitao Cheng, Lei Ji, Qinghe Cai, Yong Feng, Huahua Tu. LncRNA DARS-AS1 aggravates the growth and metastasis of hepatocellular carcinoma via regulating the miR-3200-5p-Cytoskeleton associated protein 2 (CKAP2) axis. Bioengineered 2021; 12(1) doi: 10.1080/21655979.2021.1982272
|
| 186 |
Xiwu Ouyang, Lemeng Feng, Lei Yao, Jingyu Zhang, Yao Xiao, Guodong Liu, Gewen Zhang, Zhiming Wang. A comprehensive analysis of FOX family in HCC and experimental evidence to support the oncogenic role of FOXH1. Aging 2022; 14(5) doi: 10.18632/aging.203934
|
| 187 |
Shanshan Chen, Hao Chen, Shanshan Gao, Shili Qiu, Hu Zhou, Mingxia Yu, Jiancheng Tu. Differential expression of plasma microRNA‐125b in hepatitis B virus‐related liver diseases and diagnostic potential for hepatitis B virus‐induced hepatocellular carcinoma. Hepatology Research 2017; 47(4) doi: 10.1111/hepr.12739
|
| 188 |
Valerie Chew, Yun Hua Lee, Lu Pan, Nurul J M Nasir, Chun Jye Lim, Camillus Chua, Liyun Lai, Sharifah Nur Hazirah, Tony Kiat Hon Lim, Brian K P Goh, Alexander Chung, Richard H G Lo, David Ng, Rene L F Filarca, Salvatore Albani, Pierce K H Chow. Immune activation underlies a sustained clinical response to Yttrium-90 radioembolisation in hepatocellular carcinoma. Gut 2019; 68(2) doi: 10.1136/gutjnl-2017-315485
|
| 189 |
Hui‐Huang Lai, Chih‐Wei Li, Chih‐Chen Hong, Hung‐Yu Sun, Ching‐Feng Chiu, Da‐Liang Ou, Pai‐Sheng Chen. TARBP2‐mediated destabilization of Nanog overcomes sorafenib resistance in hepatocellular carcinoma. Molecular Oncology 2019; 13(4) doi: 10.1002/1878-0261.12449
|
| 190 |
Marei Sammar, Basheer Abu‑Farich, Ibrahim Rayan, Mizied Falah, Anwar Rayan. Correlation between cytotoxicity in cancer cells and free radical‑scavenging activity: In�vitro evaluation of 57 medicinal and edible plant extracts. Oncology Letters 2019; doi: 10.3892/ol.2019.11054
|
| 191 |
Ho-Cheng Wu, Ming-Jen Cheng, Chia-Hung Yen, Yi-Ming Arthur Chen, Yi-Siao Chen, Ih-Sheng Chen, Hsun-Shuo Chang. Chemical Constituents with GNMT-Promoter-Enhancing and NRF2-Reduction Activities from Taiwan Agarwood Excoecaria formosana. Molecules 2020; 25(7) doi: 10.3390/molecules25071746
|
| 192 |
Darren Hiu-Sun Foog, Deborah Kwok, Becky Ching-Yeung Yu, Vincent Wai-Sun Wong. Managing HCC in NAFLD. Current Hepatology Reports 2017; 16(4) doi: 10.1007/s11901-017-0376-4
|
| 193 |
Chin-Chuan Chen, Chi-Yuan Chen, Shu-Huei Wang, Chau-Ting Yeh, Shih-Chi Su, Shir-Hwa Ueng, Wen-Yu Chuang, Chuen Hsueh, Tong-Hong Wang. Melatonin Sensitizes Hepatocellular Carcinoma Cells to Chemotherapy Through Long Non-Coding RNA RAD51-AS1-Mediated Suppression of DNA Repair. Cancers 2018; 10(9) doi: 10.3390/cancers10090320
|
| 194 |
S. Zheng, T.C. Chen. Fish and Fish Oil in Health and Disease Prevention. 2016; doi: 10.1016/B978-0-12-802844-5.00023-3
|
| 195 |
Kai Zhu, Wenwen Huang, Wenju Wang, Liwei Liao, Shuo Li, Songlin Yang, Jingyi Xu, Lin Li, Mingyao Meng, Yanhua Xie, Shan He, Weiwei Tang, Haodong Zhou, Luxin Liang, Hui Gao, Yiyi Zhao, Zongliu Hou, Jing Tan, Ruhong Li. Up-regulation of S100A4 expression by HBx protein promotes proliferation of hepatocellular carcinoma cells and its correlation with clinical survival. Gene 2020; 749 doi: 10.1016/j.gene.2020.144679
|
| 196 |
John A. Onofrey, Lawrence H. Staib, Xiaojie Huang, Fan Zhang, Xenophon Papademetris, Dimitris Metaxas, Daniel Rueckert, James S. Duncan. Sparse Data–Driven Learning for Effective and Efficient Biomedical Image Segmentation. Annual Review of Biomedical Engineering 2020; 22(1) doi: 10.1146/annurev-bioeng-060418-052147
|
| 197 |
Davide Chicco, Luca Oneto. Computational intelligence identifies alkaline phosphatase (ALP), alpha-fetoprotein (AFP), and hemoglobin levels as most predictive survival factors for hepatocellular carcinoma. Health Informatics Journal 2021; 27(1) doi: 10.1177/1460458220984205
|
| 198 |
ZeBing Song, GuoPei Zhang, Yang Yu, ShaoQiang Li. A Prognostic Autophagy-Related Gene Pair Signature and Small-Molecule Drugs for Hepatocellular Carcinoma. Frontiers in Genetics 2021; 12 doi: 10.3389/fgene.2021.689801
|
| 199 |
Sridhar Krishnamoorthy, J. Kalaivannan, Santhini Arulselvi Kaliyaperumal, Sangeetha Kasinathan. Phytochemical Profiling and <i>In Silico</i> Approach for Hepato-protective Activity of Various Extracts of <i>Boerhavia diffusa</i> Linn. Journal of Natural Remedies 2025; doi: 10.18311/jnr/2025/34179
|
| 200 |
Yue YANG, Yan LIAO, Yan-Ping GUI, Li ZHAO, Lu-Bo GUO. GL-V9 reverses adriamycin resistance in hepatocellular carcinoma cells by affecting JNK2-related autophagy. Chinese Journal of Natural Medicines 2020; 18(7) doi: 10.1016/S1875-5364(20)30059-5
|
| 201 |
Michal S. Shoshan, Thomas Vonderach, Bodo Hattendorf, Helma Wennemers. Peptide‐Coated Platinum Nanoparticles with Selective Toxicity against Liver Cancer Cells. Angewandte Chemie International Edition 2019; 58(15) doi: 10.1002/anie.201813149
|
| 202 |
Ayush Amod, Sonu Pahal, Princy Choudhary, Ayushi Gupta, Sangeeta Singh. Network pharmacological evaluation of strigolactones efficacy as potential inhibitors against therapeutic targets of hepatocellular carcinoma. Biotechnology Letters 2022; 44(7) doi: 10.1007/s10529-022-03266-7
|
| 203 |
Pei-Yi Chu, Shiao-Lin Tung, Kuo-Wang Tsai, Fang-Ping Shen, Shih-Hsuan Chan. Identification of the Novel Oncogenic Role of SAAL1 and Its Therapeutic Potential in Hepatocellular Carcinoma. Cancers 2020; 12(7) doi: 10.3390/cancers12071843
|
| 204 |
S. V. Gautier, A. R. Monakhov, O. M. Tsirulnikova, S. I. Zubenko, E. V. Sitnikova, D. V. Umrik, K. A. Nosov, N. D. Kurtak. Outcomes of liver transplantation in hepatocellular carcinoma: a single-center experience. Annaly khirurgicheskoy gepatologii = Annals of HPB Surgery 2020; 25(2) doi: 10.16931/1995-5464.2020267-76
|
| 205 |
Gohar Shahwar Manzar, Brian Sandeep De, Chike Osita Abana, Sunyoung S. Lee, Milind Javle, Ahmed O. Kaseb, Jean-Nicolas Vauthey, Hop Sanderson Tran Cao, Albert C. Koong, Grace Li Smith, Cullen M. Taniguchi, Emma Brey Holliday, Prajnan Das, Eugene Jon Koay, Ethan Bernard Ludmir. Outcomes and Toxicities of Modern Combined Modality Therapy with Atezolizumab Plus Bevacizumab and Radiation Therapy for Hepatocellular Carcinoma. Cancers 2022; 14(8) doi: 10.3390/cancers14081901
|
| 206 |
Chi-Yuan Chen, Jia-You Fang, Chin-Chuan Chen, Wen-Yu Chuang, Yann-Lii Leu, Shir-Hwa Ueng, Li-Shan Wei, Shu-Fang Cheng, Chuen Hsueh, Tong-Hong Wang. 2-O-Methylmagnolol, a Magnolol Derivative, Suppresses Hepatocellular Carcinoma Progression via Inhibiting Class I Histone Deacetylase Expression. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.01319
|
| 207 |
Vishnu M. Chandra, Luke R. Wilkins, David L. Brautigan. Animal Models of Hepatocellular Carcinoma for Local-Regional Intraarterial Therapies. Radiology: Imaging Cancer 2022; 4(4) doi: 10.1148/rycan.210098
|
| 208 |
Jing Ding, Bin Tang, Xiaolei Liu, Xue Bai, Yang Wang, Shicun Li, Jian Li, Mingyuan Liu, Xuelin Wang. Excretory-secretory product of Trichinella spiralis inhibits tumor cell growth by regulating the immune response and inducing apoptosis. Acta Tropica 2022; 225 doi: 10.1016/j.actatropica.2021.106172
|
| 209 |
Fengjie Xu, Runzhui Lin, Jianrui Liu, Zeming Chen, Hua Zhuo, Xingmu Liu, Dong-Hua Yang. Intravenous Immunoglobulin Inhibits Liver Cancer Progression by Promoting p38MAPK-Associated Apoptosis. Journal of Oncology 2022; 2022 doi: 10.1155/2022/1300989
|
| 210 |
Niamat Ullah Khan, Asma Sadiq, Jadoon Khan, Nosheen Basharat, Zulfiqar Ul Hassan, Ijaz Ali, Tawaf Ali Shah, Mohammed Bourhia, Yousef A. Bin Jardan, Gezahign Fentahun Wondmie. Molecular characterization of plasma virome of hepatocellular carcinoma (HCC) patients. AMB Express 2024; 14(1) doi: 10.1186/s13568-024-01696-2
|
| 211 |
Dhandhukiya Manavkumar Kanubhai, Saiyed Musaratafrin Sabirali. Hepatocellular Carcinoma: A Review. Asian Journal of Research in Pharmaceutical Sciences 2023; doi: 10.52711/2231-5659.2023.00030
|
| 212 |
Ke Zhang, Li Jiang, Zhe Jia, Yao Zhang, Rong He, Zhenhao Ding, Yi Mu. Radiofrequency Ablation Plus Devascularization Is the Preferred Treatment of Hepatocellular Carcinoma with Esophageal Varices. Digestive Diseases and Sciences 2015; 60(5) doi: 10.1007/s10620-014-3455-1
|
| 213 |
Shinu Chacko, Subir Samanta. “Hepatocellular carcinoma: A life-threatening disease”. Biomedicine & Pharmacotherapy 2016; 84 doi: 10.1016/j.biopha.2016.10.078
|
| 214 |
Akhtar Atiya, Barij Nayan Sinha, Uma Ranjan Lal. New chemical constituents from the Piper betle Linn. (Piperaceae). Natural Product Research 2018; 32(9) doi: 10.1080/14786419.2017.1380018
|
| 215 |
Vishnu Raman, Nele Van Dessel, Christopher L. Hall, Victoria E. Wetherby, Samantha A. Whitney, Emily L. Kolewe, Shoshana M. K. Bloom, Abhinav Sharma, Jeanne A. Hardy, Mathieu Bollen, Aleyde Van Eynde, Neil S. Forbes. Intracellular delivery of protein drugs with an autonomously lysing bacterial system reduces tumor growth and metastases. Nature Communications 2021; 12(1) doi: 10.1038/s41467-021-26367-9
|
| 216 |
Diwakar Suresh, Akshatha N. Srinivas, Akila Prashant, Kuzhuvelil B. Harikumar, Divya P. Kumar. Therapeutic options in hepatocellular carcinoma: a comprehensive review. Clinical and Experimental Medicine 2023; 23(6) doi: 10.1007/s10238-023-01014-3
|
| 217 |
Shinu Chacko, Subir Samanta. A novel approach towards design, synthesis and evaluation of some Schiff base analogues of 2-aminopyridine and 2-aminobezothiazole against hepatocellular carcinoma. Biomedicine & Pharmacotherapy 2017; 89 doi: 10.1016/j.biopha.2017.01.108
|
| 218 |
Jie-Fei Miao, Yan-Fu Peng, Shi Chen, Wei-Jie Gao, Qiu-Xing Yang, Peng Zhu, Jing Guo, Jinhua Tao, Lin Luo, Yanan Zhang, Yong Ling. A novel harmine derivative, N-(4-(hydroxycarbamoyl)benzyl)-1-(4- methoxyphenyl)-9H-pyrido[3,4-b]indole-3-carboxamide (HBC), as histone deacetylase inhibitor: in vitro antiproliferation, apoptosis induction, cell cycle arrest, and antimetastatic effects. European Journal of Pharmacology 2018; 824 doi: 10.1016/j.ejphar.2018.02.004
|
| 219 |
Ning Bai, Eming Peng, Xingsheng Qiu, Ning Lyu, Zhejia Zhang, Yiming Tao, Xinying Li, Zhiming Wang. circFBLIM1 act as a ceRNA to promote hepatocellular cancer progression by sponging miR-346. Journal of Experimental & Clinical Cancer Research 2018; 37(1) doi: 10.1186/s13046-018-0838-8
|
| 220 |
Baolai Zhang, Shuhong Dong, Zhongxin Li, Li Lu, Su Zhang, Xue Chen, Xiaobo Cen, Yongjie Wu. Targeting protein arginine methyltransferase 5 inhibits human hepatocellular carcinoma growth via the downregulation of beta-catenin. Journal of Translational Medicine 2015; 13(1) doi: 10.1186/s12967-015-0721-8
|
| 221 |
RESHMA T. MATE, ANURADHA N. CHIVATE, NAMDEO R. JADHAV, NIRANJAN D. CHIVATE. ADVANCING CURCUMIN APPLICATIONS IN HEPATOCELLULAR CARCINOMA: INSIGHTS INTO PHARMACOKINETICS, PHARMACODYNAMICS AND NANODELIVERY SYSTEMS. International Journal of Applied Pharmaceutics 2025; doi: 10.22159/ijap.2025v17i4.53730
|
| 222 |
Gaëtan-Romain Joliat, Pierre Allemann, Ismail Labgaa, Nicolas Demartines, Nermin Halkic. Treatment and outcomes of recurrent hepatocellular carcinomas. Langenbeck's Archives of Surgery 2017; 402(5) doi: 10.1007/s00423-017-1582-9
|
| 223 |
Jia-Cheng Tang, Yi-Li Feng, Xiao Liang, Xiu-Jun Cai. Autophagy in 5-Fluorouracil Therapy in Gastrointestinal Cancer. Chinese Medical Journal 2016; 129(4) doi: 10.4103/0366-6999.176069
|
| 224 |
Daisuke Yasuda, Tomoyuki Ohe, Kyoko Takahashi, Riyo Imamura, Hirotatsu Kojima, Takayoshi Okabe, Yoshinobu Ichimura, Masaaki Komatsu, Masayuki Yamamoto, Tetsuo Nagano, Tadahiko Mashino. Inhibitors of the protein–protein interaction between phosphorylated p62 and Keap1 attenuate chemoresistance in a human hepatocellular carcinoma cell line. Free Radical Research 2020; 54(11-12) doi: 10.1080/10715762.2020.1732955
|
| 225 |
Qing Lei, Xin Yan, Huimin Zou, Yixuan Jiang, Yunfeng Lai, Carolina Oi Lam Ung, Hao Hu. Efficacy and safety of monotherapy and combination therapy of immune checkpoint inhibitors as first-line treatment for unresectable hepatocellular carcinoma: a systematic review, meta-analysis and network meta-analysis. Discover Oncology 2022; 13(1) doi: 10.1007/s12672-022-00559-1
|
| 226 |
Li-Juan Deng, Yu-He Lei, Jing-Yu Quan, Bao-Jing Li, Dong-Mei Zhang, Hai-Yan Tian, Ye Chen, En-Xin Zhang, Lei Chen, Wen-Cai Ye, Wei-Min Ning, Lin-Zhong Yu, Jun-Shan Liu. 1β–OH–arenobufagin induces mitochondrial apoptosis in hepatocellular carcinoma through the suppression of mTOR signaling pathway. Journal of Ethnopharmacology 2021; 266 doi: 10.1016/j.jep.2020.113443
|
| 227 |
Guo Tian, Shigui Yang, Jinqiu Yuan, Diane Threapleton, Qiyu Zhao, Fen Chen, Hongcui Cao, Tian’an Jiang, Lanjuan Li. Comparative efficacy of treatment strategies for hepatocellular carcinoma: systematic review and network meta-analysis. BMJ Open 2018; 8(10) doi: 10.1136/bmjopen-2017-021269
|
| 228 |
Tejaswi Worlikar, Mishal Mendiratta-Lala, Eli Vlaisavljevich, Ryan Hubbard, Jiaqi Shi, Timothy L. Hall, Clifford S. Cho, Fred T. Lee, Joan Greve, Zhen Xu.
Effects of Histotripsy on Local Tumor Progression in an
in vivo
Orthotopic Rodent Liver Tumor Model
. BME Frontiers 2020; 2020 doi: 10.34133/2020/9830304
|
| 229 |
Amanda Kuan, Lawrence Khoo, Sam S. Yang, Hui Yi Chia, Joyce S. S. Lee. Retiform Purpura as a Complication of Microsphere Emboli Following Transarterial Chemoembolization for Primary Hepatocellular Carcinoma: A Case Report and Literature Review. The American Journal of Dermatopathology 2020; 42(7) doi: 10.1097/DAD.0000000000001586
|
| 230 |
Chiao-Fang Teng, Han-Chieh Wu, Woei-Cherng Shyu, Long-Bin Jeng, Ih-Jen Su. Pre-S2 Mutant-Induced Mammalian Target of Rapamycin Signal Pathways as Potential Therapeutic Targets for Hepatitis B Virus-Associated Hepatocellular Carcinoma. Cell Transplantation 2017; 26(3) doi: 10.3727/096368916X694382
|
| 231 |
Qinggong Yuan, Yan Zhang, Junhui Li, Di Zhang, Wenbin Yang. Circ_TEX2 Functions as a Tumor Suppressor in Hepatoma via miR-96-5p/SPRED1 Axis. Molecular Biotechnology 2023; 65(10) doi: 10.1007/s12033-023-00669-3
|
| 232 |
Rehab M. Golam, Mahmoud A. F. Khalil, Olfat G. Shaker, Tarek I. Ahmed, Mohamed K. Abd Elguaad, Essam A. Hassan, Mahmoud R. M. El-Ansary, Ahmed Ismail, Yasser I. Kandil, Osama A. Mohammed, Ahmed S. Doghish, Bruno Bernardes de Jesus. The clinical significance of long non-coding RNAs MALAT1 and CASC2 in the diagnosis of HCV-related hepatocellular carcinoma. PLOS ONE 2024; 19(5) doi: 10.1371/journal.pone.0303314
|
| 233 |
Ting-Tsung Chang, Cheng-Hsun Ho, Matias A. Avila. Plasma proteome atlas for differentiating tumor stage and post-surgical prognosis of hepatocellular carcinoma and cholangiocarcinoma. PLOS ONE 2020; 15(8) doi: 10.1371/journal.pone.0238251
|
| 234 |
Yi Huang, Jiaying Zheng, Dunyan Chen, Feng Li, Wenbing Wu, Xiaoli Huang, Yanan Wu, Yangyang Deng, Funan Qiu. Transcriptome profiling identifies a recurrent CRYL1-IFT88 chimeric transcript in hepatocellular carcinoma. Oncotarget 2017; 8(25) doi: 10.18632/oncotarget.17244
|
| 235 |
Zhi Wei Lim, Vijaykumar B. Varma, Raju V. Ramanujan, Ali Miserez. Magnetically responsive peptide coacervates for dual hyperthermia and chemotherapy treatments of liver cancer. Acta Biomaterialia 2020; 110 doi: 10.1016/j.actbio.2020.04.024
|
| 236 |
Sai Sandeep Annamaraju, Sai Charitha Mullaguri, Sharat Putta, Ravikanth Vishnubhotla, Rama Krishna Kancha. Biomedical Aspects of Solid Cancers. 2024; doi: 10.1007/978-981-97-1802-3_6
|
| 237 |
Ayoub Lafnoune, Su-Yeon Lee, Jin-Yeong Heo, Imane Gourja, Bouchra Darkaoui, Zaineb Abdelkafi-Koubaa, Fatima Chgoury, Khadija Daoudi, Salma Chakir, Rachida Cadi, Khadija Mounaji, Najet Srairi-Abid, Naziha Marrakchi, David Shum, Haeng-Ran Seo, Naoual Oukkache. Anti-Cancer Effect of Moroccan Cobra Naja haje Venom and Its Fractions against Hepatocellular Carcinoma in 3D Cell Culture. Toxins 2021; 13(6) doi: 10.3390/toxins13060402
|
| 238 |
Yuhan Jia, Yihan Zhang, Qing Xu. Preliminary Exploration on Effects ff Monocyte/Macrophage on Proliferation, Cell Death, and Migration ff Liver Cancer. 2021 13th International Conference on Bioinformatics and Biomedical Technology 2021; doi: 10.1145/3473258.3473294
|
| 239 |
Huimin Zou, Meng Li, Qing Lei, Zejun Luo, Yan Xue, Dongning Yao, Yunfeng Lai, Carolina Oi Lam Ung, Hao Hu. Economic Burden and Quality of Life of Hepatocellular Carcinoma in Greater China: A Systematic Review. Frontiers in Public Health 2022; 10 doi: 10.3389/fpubh.2022.801981
|
| 240 |
Chin-Tsung Ting, Yung-Yi Cheng, Tung-Hu Tsai. Preclinical Pharmacokinetic Interaction and Histopathological
Analyses of Hedyotis diffusa on Sorafenib
in Rats. ACS Omega 2021; 6(4) doi: 10.1021/acsomega.0c05461
|
| 241 |
Gang Wu, Zhixi Li, Youyu Wang, Xueming Ju, Rui Huang. miR-34a Inhibits Cell Proliferation by Targeting SATB2 in Hepatocellular Carcinoma. BioMed Research International 2018; 2018 doi: 10.1155/2018/2863902
|
| 242 |
Zhi Zhang, Cheng-Zu He, Ya-Qin Qin, Jian-Jun Liao, Shang-Tao Huang, Steven Mo, Hong-Mian Li, Jian-Yan Lin. Exploring the mechanism of resistance to sorafenib in two hepatocellular carcinoma cell lines. Aging 2020; 12(23) doi: 10.18632/aging.104195
|
| 243 |
Pan Yu, Shuaiyang Jing, Sarinder Kaur Dhillon. Anoikis- and m6A-related lncRNA analysis to identify prognostic indicators in liver hepatocellular carcinoma. Electronic Journal of Biotechnology 2026; 79 doi: 10.1016/j.ejbt.2025.100701
|
| 244 |
Hitoshi Sato, Marlen Doskali, Zarina Balmaganbet, Beibarys Mukhitdin, Nurzhanyat Ablaikhanova, Y. Alibek. Selective cytotoxicity and anticancer activity: ROS-induced cell death facilitated by metal complex. BIO Web of Conferences 2024; 100 doi: 10.1051/bioconf/202410001013
|
| 245 |
Yongwei Li, Yujie Li, Zengcheng Zou, Yue Li, Heping Xie, Hongzhi Yang. Yin Yang Gong Ji pill is an ancient formula with antitumor activity against hepatoma cells. Journal of Ethnopharmacology 2020; 248 doi: 10.1016/j.jep.2019.112267
|
| 246 |
Lin Chen, Haitao Guan, Chunyan Gu, Yali Cao, Jianguo Shao, Feng Wang. miR-383 inhibits hepatocellular carcinoma cell proliferation via targeting APRIL. Tumor Biology 2016; 37(2) doi: 10.1007/s13277-015-4071-1
|
| 247 |
Jian Pu, Jianchu Wang, Zuoming Xu, Yuan Lu, Xianjian Wu, Yi Wu, Zesheng Shao, Qianli Tang, Huamei Wei. miR-632 Functions as Oncogene in Hepatocellular Carcinoma via Targeting MYCT1. Human Gene Therapy Clinical Development 2019; 30(2) doi: 10.1089/humc.2019.040
|
| 248 |
Kai-Wen Chen, Tzu-Ming Ou, Chin-Wen Hsu, Chi-Ting Horng, Ching-Chang Lee, Yuh-Yuan Tsai, Chi-Chang Tsai, Yi-Sheng Liou, Chen-Chieh Yang, Chao-Wen Hsueh, Wu-Hsien Kuo. Current systemic treatment of hepatocellular carcinoma: A review of the literature. World Journal of Hepatology 2015; 7(10): 1412-1420 doi: 10.4254/wjh.v7.i10.1412
|
| 249 |
Gang-Hua Lin, Yu-Lueng Shih. Paraplegia following transarterial chemoembolisation for hepatocellular carcinoma: a case report. Acta Chirurgica Belgica 2021; 121(6) doi: 10.1080/00015458.2020.1726097
|
| 250 |
Christopher Wittmann, Anastasiia S. Sivchenko, Felix Bacher, Kelvin K. H. Tong, Navjot Guru, Thomas Wilson, Junior Gonzales, Hartmut Rauch, Susanne Kossatz, Thomas Reiner, Maria V. Babak, Vladimir B. Arion. Inhibition of Microtubule Dynamics in Cancer Cells by Indole-Modified Latonduine Derivatives and Their Metal Complexes. Inorganic Chemistry 2022; 61(3) doi: 10.1021/acs.inorgchem.1c03154
|
| 251 |
Y. Chen, S. Song, L. Zhang, Y. Zhang. Circular RNA hsa_circ_0091579 facilitates the Warburg effect and malignancy of hepatocellular carcinoma cells via the miR-624/H3F3B axis. Clinical and Translational Oncology 2021; 23(11) doi: 10.1007/s12094-021-02627-4
|
| 252 |
Mohammad Amin Shahrbaf, Kian Goudarzi, Kimia Karimi Taheri, Hani Keshavarz Alikhani, Masoumeh Noori. Chimeric antigen receptor (CAR) T cell therapy in hepatocellular carcinoma; a review of recent advances. Modern Medical Laboratory Journal 2021; 4(2) doi: 10.30699/mmlj17.4.2.19
|
| 253 |
Chen Huang, Chenliang Zhang, Jiajin Li, Yichun Duan, Qiulin Tang, Feng Bi. Targeting p38γ synergistically enhances sorafenib-induced cytotoxicity in hepatocellular carcinoma. Cell Biology and Toxicology 2025; 41(1) doi: 10.1007/s10565-024-09979-x
|
| 254 |
Serkan Kuyumcu, Duygu Has-Simsek, Raim Iliaz, Yasemin Sanli, Fikret Buyukkaya, Filiz Akyuz, Cuneyt Turkmen. Evidence of Prostate-Specific Membrane Antigen Expression in Hepatocellular Carcinoma Using 68Ga-PSMA PET/CT. Clinical Nuclear Medicine 2019; 44(9) doi: 10.1097/RLU.0000000000002701
|
| 255 |
Chao-Bin He, Xiang-Ming Lao, Xiao-Jun Lin. Transarterial chemoembolization combined with recombinant human adenovirus type 5 H101 prolongs overall survival of patients with intermediate to advanced hepatocellular carcinoma: a prognostic nomogram study. Chinese Journal of Cancer 2017; 36(1) doi: 10.1186/s40880-017-0227-2
|
| 256 |
Zhongdong Hu, Ailin Yang, Guozhu Su, Yunfang Zhao, Ying Wang, Xingyun Chai, Pengfei Tu. Huaier restrains proliferative and invasive potential of human hepatoma SKHEP-1 cells partially through decreased Lamin B1 and elevated NOV. Scientific Reports 2016; 6(1) doi: 10.1038/srep31298
|
| 257 |
Jin Won Chang, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Yeon Seok Seo, Han Ah Lee, Mi Na Kim, Yu Rim Lee, Seong Gyu Hwang, Kyu Sung Rim, Soon Ho Um, Won Young Tak, Young Oh Kweon, Soo Young Park, Seung Up Kim. Validation of risk prediction scores for hepatocellular carcinoma in patients with chronic hepatitis B treated with entecavir or tenofovir. Journal of Viral Hepatitis 2021; 28(1) doi: 10.1111/jvh.13411
|
| 258 |
Mushira Khanam, Abu Tayab Moin, Kazi Ahsan Ahmed, Rajesh B. Patil, Abul Bashar Ripon Khalipha, Nafisa Ahmed, Rajat Bagchi, Md Asad Ullah, Jannatul Ferdoush, Saiful Islam, Bashudev Rudra. Computational modeling of potential milciclib derivatives inhibitor-CDK2 binding through global docking and accelerated molecular dynamics simulations. Informatics in Medicine Unlocked 2022; 33 doi: 10.1016/j.imu.2022.101069
|
| 259 |
M.H. Mohamed-Chairi, A.B. Vico-Arias, N. Zambudio-Carroll, M.T. Villegas-Herrera, J.M. Villar-del-Moral. Análisis comparativo de pacientes trasplantados por carcinoma hepatocelular. ¿Hay diferencias en cuanto a supervivencia entre los que cumplen criterios de Milán y los que los exceden?. Revista de Gastroenterología de México 2025; 90(1) doi: 10.1016/j.rgmx.2024.06.003
|
| 260 |
Jaewoo Hong, Soohyun Kim, P. Charles Lin. Interleukin-33 and ST2 Signaling in Tumor Microenvironment. Journal of Interferon & Cytokine Research 2019; 39(1) doi: 10.1089/jir.2018.0044
|
| 261 |
Sarinya Palakhachane, Yuwaporn Ketkaew, Natthaya Chuaypen, Jitnapa Sirirak, Jutatip Boonsombat, Somsak Ruchirawat, Pisit Tangkijvanich, Apichart Suksamrarn, Panupun Limpachayaporn. Synthesis of sorafenib analogues incorporating a 1,2,3-triazole ring and cytotoxicity towards hepatocellular carcinoma cell lines. Bioorganic Chemistry 2021; 112 doi: 10.1016/j.bioorg.2021.104831
|
| 262 |
Jyh-Jou Chen, Sheng-Shiung Huang, In-Fun Li, Kuan-Pin Lin, Shiow-Luan Tsay. Prognostic association of demographic and clinical factors with the change rates of symptoms and depression among patients with hepatocellular carcinoma. Supportive Care in Cancer 2019; 27(12) doi: 10.1007/s00520-019-04776-3
|
| 263 |
Tommaso Vincenzo Bartolotta, Adele Taibbi, Massimo Midiri, Roberto Lagalla. Contrast-enhanced ultrasound of hepatocellular carcinoma: where do we stand?. Ultrasonography 2019; 38(3) doi: 10.14366/usg.18060
|
| 264 |
S. Jain. Can Schistosoma japonicum infection cause liver cancer?. Journal of Helminthology 2025; 99 doi: 10.1017/S0022149X24000762
|
| 265 |
Tülay AŞKIN ÇELİK, Özlem Sultan ASLANTÜRK, Ebru Şebnem YILMAZ, Yelda GÜZEL. Fumaria parviflora Lam. ve Fumaria capreolata L.’nin Antioksidan ve Sitotoksik Aktiviteleri. Kahramanmaraş Sütçü İmam Üniversitesi Tarım ve Doğa Dergisi 2022; 25(4) doi: 10.18016/ksutarimdoga.vi.899937
|
| 266 |
Nada Chaoul, Serena Mancarella, Luigi Lupo, Gianluigi Giannelli, Francesco Dituri. Impaired Anti-Tumor T cell Response in Hepatocellular Carcinoma. Cancers 2020; 12(3) doi: 10.3390/cancers12030627
|
| 267 |
Thomas Vogl, Hamzah Adwan, Jörg Trojan, Nagy Naguib, Tatjana Gruber-Rouh. Interventional Treatment in Small-Sized Hepatocellular Carcinoma Using Microwave Ablation: Evaluation of Local Response and Survival. EMJ Radiology 2023; doi: 10.33590/emjradiol/10303169
|
| 268 |
Jeannette Huaman, Cuong Bach, Adeodat Ilboudo, Olorunseun O. Ogunwobi. Precision Molecular Pathology of Liver Cancer. Molecular Pathology Library 2018; doi: 10.1007/978-3-319-68082-8_8
|
| 269 |
Angela Giselvania, Vetnizah Juniantito, Heri Wibowo, Trifonia Siregar, Soehartati Gondhowiardjo. Induction of Hepatocellular Carcinoma in Conventional Domestic Swine Using N-Diethylnitrosamine and Phenobarbital. Cancer Management and Research 2024; doi: 10.2147/CMAR.S439787
|
| 270 |
Nayantara Orekondy, Sheila Eswaran. Misconceptions Surrounding Hepatocellular Carcinoma. Clinical Liver Disease 2018; 12(6) doi: 10.1002/cld.752
|
| 271 |
B. N. Kotiv, I. I. Dzidzava, S. A. Alent’yev, A. V. Smorodsky, K. I. Makhmudov, A. A. Apollonov, S. A. Soldatov, P. N. Zubarev. Complex treatment of hepatocellular carcinoma at early (BCLC-A) and intermediate (BCLC-B) stages. Annaly khirurgicheskoy gepatologii = Annals of HPB Surgery 2020; 25(2) doi: 10.16931/1995-5464.2020255-66
|
| 272 |
Lin Chen, Feihu Chu, Yali Cao, Jianguo Shao, Feng Wang. Serum miR-182 and miR-331-3p as diagnostic and prognostic markers in patients with hepatocellular carcinoma. Tumor Biology 2015; 36(10) doi: 10.1007/s13277-015-3430-2
|
| 273 |
Deborah A Boyle. Hepatocellular carcinoma: Implications for Asia-Pacific Oncology Nurses. Asia-Pacific Journal of Oncology Nursing 2017; 4(2) doi: 10.4103/2347-5625.204497
|
| 274 |
Young-Jen Lin, Cheng-Maw Ho. Is the Rationale of Anatomical Liver Resection for Hepatocellular Carcinoma Universally Adoptable? A Hypothesis-Driven Review. Medicina 2021; 57(2) doi: 10.3390/medicina57020131
|
| 275 |
Sohyeon Park, Yoonjin Park, Heejong Shin, Boyong Kim, Seunggwan Lee. Effect of Allium senescens Extract on Sorafenib Resistance in Hepatocarcinoma Cells. Applied Sciences 2021; 11(8) doi: 10.3390/app11083696
|
| 276 |
Vanessa Chan, April St Pierre, Tien Do, Shyh-Dar Li. Emerging vesicular nanosystems capable of effectively targeting hepatocytes. Nanomedicine 2025; 20(15) doi: 10.1080/17435889.2025.2534326
|
| 277 |
Sonia Simón Serrano, Michele Tavecchio, Josef Mallik, Alvar Grönberg, Eskil Elmér, Chamseddine Kifagi, Philippe Gallay, Magnus Joakim Hansson, Ramin Massoumi. Synergistic Effects of Sanglifehrin-Based Cyclophilin Inhibitor NV651 with Cisplatin in Hepatocellular Carcinoma. Cancers 2022; 14(19) doi: 10.3390/cancers14194553
|
| 278 |
Hiroki Kamioka, Kazue Edaki, Haruka Kasahara, Takumi Tomono, Kentaro Yano, Takuo Ogihara. Drug resistance via radixin-mediated increase of P-glycoprotein membrane expression during SNAI1-induced epithelial-mesenchymal transition in HepG2 cells. Journal of Pharmacy and Pharmacology 2021; 73(12) doi: 10.1093/jpp/rgab051
|
| 279 |
Yikun Jiang, Shibo Wei, Jin-Mo Koo, Hea-Ju Kim, Wonyoung Park, Yan Zhang, He Guo, Ki-Tae Ha, Chang-Myung Oh, Jong-Sun Kang, Jee-Heon Jeong, Dongryeol Ryu, Kyeong-Jin Kim, Yunju Jo. Integrative Evaluation of the Clinical Significance Underlying Protein Arginine Methyltransferases in Hepatocellular Carcinoma. Cancers 2023; 15(16) doi: 10.3390/cancers15164183
|
| 280 |
Zahra Farzaneh, Massoud Vosough, Tarun Agarwal, Maryam Farzaneh. Critical signaling pathways governing hepatocellular carcinoma behavior; small molecule-based approaches. Cancer Cell International 2021; 21(1) doi: 10.1186/s12935-021-01924-w
|
| 281 |
Mohadeseh khoshandam, Nikolaos Sideris, Amirhossein Ahmadieh-Yazdi, Mohsen Sheykhhasan, Hamed Manoochehri, Hamid Tanzadehpanah, Hanie Mahaki, Mona Ghadam, Shermin lak, Naser Kalhor, Mohammad Rabiei, Sharafaldin Al-Musawi, Paola Dama. The functional role of LncRNA HOXA-AS2 in multiple human cancers. Pathology - Research and Practice 2025; 266 doi: 10.1016/j.prp.2024.155795
|
| 282 |
Shvetank Bhatt, Jovita Kanoujia, Arghya K. Dhar, Rakesh K. Singh, Jayaraman Rajangam. Current and Future Scenario of Immunotherapy for the Treatment of Hepatocellular Carcinoma. Current Cancer Therapy Reviews 2021; 17(2) doi: 10.2174/1573394716999200818103724
|
| 283 |
Hongshi Li, Ning Wei, Yi Ma, Xiaozhou Wang, Zhiqiang Zhang, Shuang Zheng, Xi Yu, Shuang Liu, Lijie He. Integrative module analysis of HCC gene expression landscapes. Experimental and Therapeutic Medicine 2020; doi: 10.3892/etm.2020.8437
|
| 284 |
Fan Zhang, Junlin Yang, Nariman Nezami, Fabian Laage-gaupp, Julius Chapiro, Ming De Lin, James Duncan. Patch-Based Techniques in Medical Imaging. Lecture Notes in Computer Science 2018; 11075 doi: 10.1007/978-3-030-00500-9_7
|
| 285 |
Pamela O'Donoghue, James O'Beirne, Massimo Malago, Lisa Woodrow, Charles Imber, Dinesh Sharma. Clinical nurse specialist role in setting up a joint hepatocellular carcinoma clinic at a specialist liver unit. Gastrointestinal Nursing 2018; 16(Sup10) doi: 10.12968/gasn.2018.16.Sup10.S20
|
| 286 |
Jian Jiang, Yaodong Chen, Tianxiu Dong, Minlu Yue, Yu Zhang, Tingting An, Jiuwei Zhang, Pengfei Liu, Xiuhua Yang. Polydatin inhibits hepatocellular carcinoma via the AKT/STAT3‑FOXO1 signaling pathway. Oncology Letters 2019; doi: 10.3892/ol.2019.10123
|
| 287 |
Yanyu Bi, Hua Jiang, Peng Wang, Bo Song, Huamao Wang, Xianming Kong, Zonghai Li. Treatment of hepatocellular carcinoma with a GPC3-targeted bispecific T cell engager. Oncotarget 2017; 8(32) doi: 10.18632/oncotarget.17905
|
| 288 |
J J Yu, F Shen, T H Chen, L Liang, J Han, H Xing, Y H Zhou, H Wang, W M Gu, W Y Lau, T Yang. Multicentre study of the prognostic impact of preoperative bodyweight on long-term prognosis of hepatocellular carcinoma. Journal of British Surgery 2019; 106(3) doi: 10.1002/bjs.10981
|
| 289 |
Darren J. H. Tan, Chloe Wong, Cheng Han Ng, Chen Wei Poh, Sneha Rajiv Jain, Daniel Q. Huang, Mark D. Muthiah. A Meta-Analysis on the Rate of Hepatocellular Carcinoma Recurrence after Liver Transplant and Associations to Etiology, Alpha-Fetoprotein, Income and Ethnicity. Journal of Clinical Medicine 2021; 10(2) doi: 10.3390/jcm10020238
|
| 290 |
Kiran Arshad, Sheikh Danial Hanan, Muhammad Numair Younis, Rimsha Badar, Minahil Imran, Nefal Numair, Abubakar Imran. Detection of Primary Hepatocellular Carcinoma on18F-Fluorodeoxyglucose Positron Emission Tomography-computed Tomography. Euroasian journal of hepato-gastroenterology 2023; 13(2) doi: 10.5005/jp-journals-10018-1409
|
| 291 |
Xiu-Tao Fu, Ying-Hong Shi, Jian Zhou, Yuan-Fei Peng, Wei-Ren Liu, Guo-Ming Shi, Qiang Gao, Xiao-Ying Wang, Kang Song, Jia Fan, Zhen-Bin Ding. Association of hepatitis status with surgical outcomes in patients with dual hepatitis B and C related hepatocellular carcinoma. Infectious Agents and Cancer 2017; 12(1) doi: 10.1186/s13027-017-0137-6
|
| 292 |
Yasunao Numata, Noriyuki Akutsu, Keisuke Ishigami, Hideyuki Koide, Kohei Wagatsuma, Masayo Motoya, Shigeru Sasaki, Hiroshi Nakase. Synergistic effect of IFN-γ and IL-1β on PD-L1 expression in hepatocellular carcinoma. Biochemistry and Biophysics Reports 2022; 30 doi: 10.1016/j.bbrep.2022.101270
|
| 293 |
Marie-Hélène Wasmer, Philippe Krebs. The Role of IL-33-Dependent Inflammation in the Tumor Microenvironment. Frontiers in Immunology 2017; 7 doi: 10.3389/fimmu.2016.00682
|
| 294 |
Kajal Singh, Pradeep Kumar, Amit Kumar Singh, Nancy Singh, Sakshi Singh, Kavindra Nath Tiwari, Shreni Agrawal, Richa Das, Anuradha Singh, Bhuwal Ram, Amit Kumar Tripathi, Sunil Kumar Mishra. In silico and network pharmacology analysis of fucosterol: a potent anticancer bioactive compound against HCC. Medical Oncology 2024; 41(6) doi: 10.1007/s12032-024-02374-w
|
| 295 |
Shiye Yang, Haishun Ni, Aixian Zhang, Jixiang Zhang, Huoqi Liang, Xing Li, Jiayi Qian, Hong Zang, Zhibing Ming. Body mass index is a risk factor for postoperative morbidity after laparoscopic hepatectomy of hepatocellular carcinoma: a multicenter retrospective study. Journal of Cancer Research and Clinical Oncology 2024; 150(10) doi: 10.1007/s00432-024-05979-w
|
| 296 |
Yinuo Li, Shosei Shimizu, Masashi Mizumoto, Takashi Iizumi, Haruko Numajiri, Hirokazu Makishima, Gong Li, Hideyuki Sakurai. Proton Beam Therapy for Multifocal Hepatocellular Carcinoma (HCC) Showing Complete Response in Pathological Anatomy After Liver Transplantation. Cureus 2022; doi: 10.7759/cureus.25744
|
| 297 |
Arturo Soriano, Aranzazu Varona, Rajesh Gianchandani, Modesto Enrique Moneva, Javier Arranz, Antonio Gonzalez, Manuel Barrera. Selection of patients with hepatocellular carcinoma for liver transplantation: Past and future. World Journal of Hepatology 2016; 8(1): 58-68 doi: 10.4254/wjh.v8.i1.58
|
| 298 |
Long Yang, Zheyue Yuan, Yamin Zhang, Zilin Cui, Yang Li, Jiancun Hou, Xiaolong Liu, Zirong Liu, Rui Shi, Qing Tian, Jian Wang, Lianjiang Wang. MiniPDX-guided postoperative anticancer treatment can effectively prolong the survival of patients with hepatocellular carcinoma. Cancer Chemotherapy and Pharmacology 2021; 87(1) doi: 10.1007/s00280-020-04182-1
|
| 299 |
Hui Xia, Pei Feng, Wei Wang, Zhao Gong, Jun Ran, Peng Lu, Bin Dai. Development of a Cancer-associated Fibroblast Signature for Evaluating Immunotherapy Response and Prognosis of Hepatocellular Carcinoma. Current Medicinal Chemistry 2025; 32(30) doi: 10.2174/0109298673322216240711113419
|
| 300 |
Suyash S. Kulkarni, Nitin Sudhakar Shetty, Shashank Mishra, David Narayan. Basics of Hepatobiliary Interventions. 2021; doi: 10.1007/978-981-15-6856-5_12
|
| 301 |
Rui Gao, Chunli Cai, Jiancheng Gan, Xi Yang, Zeyu Shuang, Min Liu, Shengping Li, Hua Tang. miR-1236 down-regulates alpha-fetoprotein, thus causing PTEN accumulation, which inhibits the PI3K/Akt pathway and malignant phenotype in hepatoma cells. Oncotarget 2015; 6(8) doi: 10.18632/oncotarget.3338
|
| 302 |
Young Kim, Christopher C. Stahl, Abouelmagd Makramalla, Olugbenga O. Olowokure, Ross L. Ristagno, Vikrom K. Dhar, Michael R. Schoech, Seetharam Chadalavada, Tahir Latif, Jordan Kharofa, Khurram Bari, Shimul A. Shah. Downstaging therapy followed by liver transplantation for hepatocellular carcinoma beyond Milan criteria. Surgery 2017; 162(6) doi: 10.1016/j.surg.2017.08.007
|
| 303 |
Maen Abdelrahim, David Victor, Abdullah Esmail, Sudha Kodali, Edward A. Graviss, Duc T. Nguyen, Linda W. Moore, Ashish Saharia, Robert McMillan, Joy N. Fong, Ahmed Uosef, Mahmoud Elshawwaf, Kirk Heyne, Rafik M. Ghobrial. Transarterial Chemoembolization (TACE) Plus Sorafenib Compared to TACE Alone in Transplant Recipients with Hepatocellular Carcinoma: An Institution Experience. Cancers 2022; 14(3) doi: 10.3390/cancers14030650
|
| 304 |
Cheng-Kun Yang, Zhong-Liu Wei, Xiao-Qiang Shen, Yu-Xuan Jia, Qiong-Yuan Wu, Yong-Guang Wei, Hao Su, Wei Qin, Xi-Wen Liao, Guang-Zhi Zhu, Tao Peng. Prognostic utility of gamma-glutamyl transpeptidase to platelet ratio in patients with solitary hepatitis B virus-related hepatocellular carcinoma after hepatectomy. World Journal of Gastrointestinal Oncology 2024; 16(12): 4579-4596 doi: 10.4251/wjgo.v16.i12.4579
|
| 305 |
Shutong Zhou, Lei Jiang, Mingxiao Sun. Recurrent Hypoglycemic Coma as the Initial and Single Clinical Manifestation of Advanced Hepatocellular Carcinoma. Journal of Gastrointestinal Cancer 2015; 46(1) doi: 10.1007/s12029-014-9670-3
|
| 306 |
Guangjiang Jiang, Sunbin Ling, Qifan Zhan, Li Zhuang, Xiao Xu. Downstaging treatment for patients with hepatocelluar carcinoma before transplantation. Transplantation Reviews 2021; 35(2) doi: 10.1016/j.trre.2021.100606
|
| 307 |
Joy Varghese, Chandan Kumar Kedarisetty, Jayanthi Venkataraman, Vijaya Srinivasan, Thiruchunapalli Deepashree, Mangerira Chinnappa Uthappa, Kaliamurthy Ilankumaran, Sanjay Govil, Mettu Srinivas Reddy, Mohamed Rela. Combination of TACE and Sorafenib Improves Outcomes in BCLC Stages B/C of Hepatocellular Carcinoma: A Single Centre Experience. Annals of Hepatology 2017; 16(2) doi: 10.5604/16652681.1231585
|
| 308 |
Dan Yue, Xun Sun. RETRACTED ARTICLE: Idelalisib promotes Bim-dependent apoptosis through AKT/FoxO3a in hepatocellular carcinoma. Cell Death & Disease 2018; 9(10) doi: 10.1038/s41419-018-0960-8
|
| 309 |
Juyoung Kim, Kyung Hee Jung, Hong Hua Yan, Min Ji Cheon, Sunmi Kang, Xing Jin, Sunghyouk Park, Myung Sook Oh, Soon-Sun Hong. Artemisia Capillaris leaves inhibit cell proliferation and induce apoptosis in hepatocellular carcinoma. BMC Complementary and Alternative Medicine 2018; 18(1) doi: 10.1186/s12906-018-2217-6
|
| 310 |
J. Anakha, Yenisetti Rajendra Prasad, Nisha Sharma, Abhay H. Pande. Human arginase I: a potential broad-spectrum anti-cancer agent. 3 Biotech 2023; 13(5) doi: 10.1007/s13205-023-03590-3
|
| 311 |
Melissa Flores-García, Roberto Arredondo-Valdés, Alejandro Zugasti-Cruz, Thelma K. Morales-Martínez, Mayela Govea-Salas, Leopoldo J. Ríos-González. The Potential of Biotechnology and Bioproducts in the Implementation of the Sustainable Development Goals. World Sustainability Series 2026; doi: 10.1007/978-3-032-10314-7_12
|
| 312 |
Tong-Hong Wang, Chau-Ting Yeh, Jar-Yi Ho, Kwai-Fong Ng, Tse-Ching Chen. OncomiR miR-96 and miR-182 promote cell proliferation and invasion through targeting ephrinA5 in hepatocellular carcinoma. Molecular Carcinogenesis 2016; 55(4) doi: 10.1002/mc.22286
|
| 313 |
Matteo Renzulli, Francesco Tovoli, Alfredo Clemente, Anna Maria Ierardi, Irene Pettinari, Giuliano Peta, Giovanni Marasco, Davide Festi, Fabio Piscaglia, Salvatore Cappabianca, Gianpaolo Carrafiello, Rita Golfieri. Ablation for hepatocellular carcinoma: beyond the standard indications. Medical Oncology 2020; 37(4) doi: 10.1007/s12032-020-01348-y
|
| 314 |
Luca Filippi, Giovan G. Di Costanzo, Antonio D’Agostini, Raffaella Tortora, Giuseppe Pelle, Roberto Cianni, Orazio Schillaci, Oreste Bagni. Decrease in total lesion glycolysis and survival after yttrium-90-radioembolization in poorly differentiated hepatocellular carcinoma with portal vein tumour thrombosis. Nuclear Medicine Communications 2018; 39(9) doi: 10.1097/MNM.0000000000000879
|
| 315 |
Daniela Coelho dos Santos, Jamal Rafique, Sumbal Saba, Gabriela M. Almeida, Tâmila Siminski, Cynthia Pádua, Danilo W. Filho, Ariane Zamoner, Antonio L. Braga, Rozangela C. Pedrosa, Fabiana Ourique. Apoptosis oxidative damage‐mediated and antiproliferative effect of selenylated imidazo[1,2‐a]pyridines on hepatocellular carcinoma HepG2 cells and in vivo. Journal of Biochemical and Molecular Toxicology 2021; 35(3) doi: 10.1002/jbt.22663
|
| 316 |
Kaja Karaś, Iwona Karwaciak, Katarzyna Chałaśkiewicz, Anna Sałkowska, Joanna Pastwińska, Rafał A. Bachorz, Marcin Ratajewski. Anti-hepatocellular carcinoma activity of the cyclin-dependent kinase inhibitor AT7519. Biomedicine & Pharmacotherapy 2023; 164 doi: 10.1016/j.biopha.2023.115002
|
| 317 |
Hadeer A Aglan, Hanaa H Ahmed, Sayed A El-Toumy, Nadia S Mahmoud. Gallic acid against hepatocellular carcinoma: An integrated scheme of the potential mechanisms of action fromin vivostudy. Tumor Biology 2017; 39(6) doi: 10.1177/1010428317699127
|
| 318 |
Mohamed Helal, Chuan Yan, Zhiyuan Gong. Stimulation of hepatocarcinogenesis by activated cholangiocytes via Il17a/f1 pathway in kras transgenic zebrafish model. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-020-80621-6
|
| 319 |
Yan Zhou, Kai Sun, Yi Ma, Haozheng Yang, Yuanliang Zhang, Xianming Kong, Lixin Wei. Autophagy inhibits chemotherapy-induced apoptosis through downregulating Bad and Bim in hepatocellular carcinoma cells. Scientific Reports 2014; 4(1) doi: 10.1038/srep05382
|
| 320 |
Thomas M. Ruli, Ethan D. Pollack, Atul Lodh, Charles D. Evers, Christopher A. Price, Mohamed Shoreibah. Immune Checkpoint Inhibitors in Hepatocellular Carcinoma and Their Hepatic-Related Side Effects: A Review. Cancers 2024; 16(11) doi: 10.3390/cancers16112042
|
| 321 |
Li-Fang Chou, Chi-Yuan Chen, Wan-Hua Yang, Chin-Chuan Chen, Junn-Liang Chang, Yann-Lii Leu, Miaw-Jene Liou, Tong-Hong Wang. Suppression of Hepatocellular Carcinoma Progression through FOXM1 and EMT Inhibition via Hydroxygenkwanin-Induced miR-320a Expression. Biomolecules 2019; 10(1) doi: 10.3390/biom10010020
|
| 322 |
LING XU, TING WANG, WEN-YING MENG, JUE WEI, JIA-LI MA, MIN SHI, YU-GANG WANG. Salinomycin inhibits hepatocellular carcinoma cell invasion and migration through JNK/JunD pathway-mediated MMP9 expression. Oncology Reports 2015; 33(3) doi: 10.3892/or.2014.3680
|
| 323 |
Sungwon Kim, Jaeseung Shin, Do-Young Kim, Gi Hong Choi, Myeong-Jin Kim, Jin-Young Choi. Radiomics on Gadoxetic Acid–Enhanced Magnetic Resonance Imaging for Prediction of Postoperative Early and Late Recurrence of Single Hepatocellular Carcinoma. Clinical Cancer Research 2019; 25(13) doi: 10.1158/1078-0432.CCR-18-2861
|
| 324 |
Wei Zhang, Kai Liu, Songyang Liu, Bai Ji, Yingchao Wang, Yahui Liu. MicroRNA-133a functions as a tumor suppressor by targeting IGF-1R in hepatocellular carcinoma. Tumor Biology 2015; 36(12) doi: 10.1007/s13277-015-3749-8
|
| 325 |
Bulent Karaman, Bilal Battal, Sebahattin Sari, Samet Verim. Hepatocellular carcinoma review: Current treatment, and evidence-based medicine. World Journal of Gastroenterology 2014; 20(47): 18059-18060 doi: 10.3748/wjg.v20.i47.18059
|
| 326 |
Pharidah Rajan Ibrahim Omar Sundi, Velaphi C. Thipe, Mohamed Abdullahi Omar, Temitope Isaac Adelusi, Jalene Gedefa, Olamide T. Olaoba. Preclinical human and murine models of hepatocellular carcinoma (HCC). Clinics and Research in Hepatology and Gastroenterology 2024; 48(7) doi: 10.1016/j.clinre.2024.102418
|
| 327 |
Xue Yang, Liankang Sun, Liang Wang, Bowen Yao, Huanye Mo, Wei Yang. LncRNA SNHG7 accelerates the proliferation, migration and invasion of hepatocellular carcinoma cells via regulating miR-122-5p and RPL4. Biomedicine & Pharmacotherapy 2019; 118 doi: 10.1016/j.biopha.2019.109386
|
| 328 |
Chi-Yuan Chen, Chin-Chuan Chen, Wen-Yu Chuang, Yann-Lii Leu, Shir-Hwa Ueng, Chuen Hsueh, Chau-Ting Yeh, Tong-Hong Wang. Hydroxygenkwanin Inhibits Class I HDAC Expression and Synergistically Enhances the Antitumor Activity of Sorafenib in Liver Cancer Cells. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.00216
|
| 329 |
XI-HUA FU, MIN LI, HAI-BO LOU, MING-SHOU HUANG, CHUN-LONG LIU. Investigating genetic characteristics of hepatitis B virus-associated and -non-associated hepatocellular carcinoma. Genetics Research 2016; 98 doi: 10.1017/S0016672316000124
|
| 330 |
Junwei Kang, Zhiying Zheng, Xian Li, Tian Huang, Dawei Rong, Xinyang Liu, Miaomiao Qin, Yuliang Wang, Xiangyi Kong, Jinhua Song, Chengyu Lv, Xiongxiong Pan. Midazolam exhibits antitumour and enhances the efficiency of Anti-PD-1 immunotherapy in hepatocellular carcinoma. Cancer Cell International 2022; 22(1) doi: 10.1186/s12935-022-02735-3
|
| 331 |
Md Mohosin Rana, Marites P. Melancon. Emerging Polymer Materials in Trackable Endovascular Embolization and Cell Delivery: From Hype to Hope. Biomimetics 2022; 7(2) doi: 10.3390/biomimetics7020077
|
| 332 |
Ying-Hsia Shih, Cheng-Liang Peng, Mao-Feng Weng, Ping-Fang Chiang, Tsai-Yueh Luo, Xi-Zhang Lin. Evaluation Efficacy of Rhenium-188-Loaded Micro-particles for Radiotherapy in a Mouse Model of Hepatocellular Carcinoma. Molecular Pharmaceutics 2019; 16(3) doi: 10.1021/acs.molpharmaceut.8b01083
|
| 333 |
Xiaohui Wang, Jiangyan Liu. Hip joint and femur metastases as the first symptom of hepatocellular carcinoma detected by bone scintigraphy. Radiology of Infectious Diseases 2015; 2(3) doi: 10.1016/j.jrid.2015.10.002
|
| 334 |
M.H. Mohamed-Chairi, A.B. Vico-Arias, N. Zambudio-Carroll, M.T. Villegas-Herrera, J.M. Villar-del-Moral. Comparative analysis of patients transplanted due to hepatocellular carcinoma. Are there survival differences between those who meet the Milan criteria and those who exceed them?. Revista de Gastroenterología de México (English Edition) 2025; 90(1) doi: 10.1016/j.rgmxen.2024.06.007
|
| 335 |
Abeer A Mabrouk, Nadia A. Eltablawy, Raouf M.M. El-Allawy, H.A. Abdel Maksoud, Yakout A. Elsenosi. The ameliorating effect of Terminalia muelleri extract on oxidative stress–related factors in induced hepatocellular carcinoma rat model. Gene Reports 2022; 26 doi: 10.1016/j.genrep.2021.101482
|
| 336 |
Angel Juarez-Flores, Marco José. Multivariate Entropy Characterizes the Gene Expression and Protein-Protein Networks in Four Types of Cancer. Entropy 2018; 20(3) doi: 10.3390/e20030154
|
| 337 |
Sang-Geun Lee, Sung Min Cho, Kum Whang, Yeon gyu Jang, Jongyeon Kim, Jongwook Choi. Spinal Cord Infarction After Transarterial Chemoembolization for Hepatocellular Carcinoma. Korean Journal of Neurotrauma 2022; 18(2) doi: 10.13004/kjnt.2022.18.e65
|
| 338 |
Fereshteh Asgharzadeh, Reza Jafarzadeh-Esfehani, Seyed M. Hassanian, Gordon A. Ferns, Amir Avan, Majid Khazaei. Renin-angiotensin System Inhibitors and Development of Hepatocellular Carcinoma: A Systematic Review and Meta-analysis. Current Pharmaceutical Design 2020; 26(39) doi: 10.2174/1381612826666200713165018
|
| 339 |
Yaobo Song, Shuang Wang, Xiangming Cheng. LINC01006 regulates the proliferation, migration and invasion of hepatocellular carcinoma cells through regulating miR-433-3p/CBX3 axis. Annals of Hepatology 2021; 25 doi: 10.1016/j.aohep.2021.100343
|
| 340 |
Khaled Mahmoud, Shady Swidan, Mohamed El-Nabarawi, Mahmoud Teaima. Lipid based nanoparticles as a novel treatment modality for hepatocellular carcinoma: a comprehensive review on targeting and recent advances. Journal of Nanobiotechnology 2022; 20(1) doi: 10.1186/s12951-022-01309-9
|
| 341 |
Lewis I. Larsen, Gabriel P. López, Reed Selwyn, Nick J. Carroll. Microfluidic Fabrication of Silica Microspheres Infused with Positron Emission Tomography Imaging Agents. ACS Applied Bio Materials 2023; 6(2) doi: 10.1021/acsabm.2c00940
|
| 342 |
Senay Mihcin, Cesare Gagliardo, Patrizia Toia, Andrew Dennison, Jan Strehlow, Andreas Melzer. MR-guided focused ultrasound application for moving target tumor ablation in abdominal area: coil selection. Acta Radiologica 2021; 62(1) doi: 10.1177/0284185120914059
|
| 343 |
Lise Wei, Dawn Owen, Benjamin Rosen, Xinzhou Guo, Kyle Cuneo, Theodore S Lawrence, Randall Ten Haken, Issam El Naqa. A deep survival interpretable radiomics model of hepatocellular carcinoma patients. Physica Medica 2021; 82 doi: 10.1016/j.ejmp.2021.02.013
|
| 344 |
. 2018; doi: 10.70675/ec7734c8zd6cdz40d5z9291ze7613c3b0d23
|
| 345 |
Nisha S. Ramani, Linda K. Green. Metastatic hepatocellular carcinoma to the bone diagnosed by fine needle aspiration in a veteran population. Diagnostic Cytopathology 2022; 50(7) doi: 10.1002/dc.24961
|
| 346 |
Jinming Zhang, Jingjing Li, Zhi Shi, Yang Yang, Xi Xie, Simon MingYuen Lee, Yitao Wang, Kam W. Leong, Meiwan Chen. pH-sensitive polymeric nanoparticles for co-delivery of doxorubicin and curcumin to treat cancer via enhanced pro-apoptotic and anti-angiogenic activities. Acta Biomaterialia 2017; 58 doi: 10.1016/j.actbio.2017.04.029
|
| 347 |
Hamada Shoaib, Amr Negm, Amira O. Abd El-Azim, Khaled A. Elawdan, Mohamed Abd-ElRazik, Rofaida Refaai, Ibrahim Helmy, Amany M. Elshamy, Hany Khalil. Ameliorative effects of Turbinaria ornata extract on hepatocellular carcinoma induced by diethylnitrosamine in-vivo. Journal of Molecular Histology 2024; 55(6) doi: 10.1007/s10735-024-10263-9
|
| 348 |
Tao Gu, Yang Ge, Yuezhang Song, Zhanzhao Fu, Yunjie Zhang, Guangxia Wang, Shasha Shao, Tao Wen. Hepatic radiofrequency ablation causes an increase of circulating histones in patients with hepatocellular carcinoma. Scandinavian Journal of Clinical and Laboratory Investigation 2015; 75(7) doi: 10.3109/00365513.2015.1050689
|
| 349 |
Moumita Maji, Indira Bhattacharya, Sourav Acharya, Manas Pratim Chakraborty, Arnab Gupta, Arindam Mukherjee. Hypoxia Active Platinum(IV) Prodrugs of Orotic Acid Selective to Liver Cancer Cells. Inorganic Chemistry 2021; 60(7) doi: 10.1021/acs.inorgchem.0c03803
|
| 350 |
Hee Jeung Oh, Mariam S. Aboian, Colin R. Yee, Michael Y. J. Yi, Jacqueline A. Maslyn, Whitney S. Loo, Bridget Kilbride, Emilie Decavel-Bueff, Adele G. Godby, Evan Bhagat, Mark W. Wilson, Carol Stillson, Terilyn Moore, Gregory R. Robbins, Steven W. Hetts. 3D Printed Biosponge Adsorbers for Capturing Toxic Chemotherapy Drugs In Situ in the Body. ACS Biomaterials Science & Engineering 2026; 12(2) doi: 10.1021/acsbiomaterials.5c01754
|
| 351 |
Eun Suk Park, Do Hoon Kwon, Jun Bum Park, Do Hee Lee, Young Hyun Cho, Jeong Hoon Kim, Chang Jin Kim. Gamma Knife surgery for treating brain metastases arising from hepatocellular carcinomas. Journal of Neurosurgery 2014; 121(Suppl_2) doi: 10.3171/2014.7.GKS141507
|
| 352 |
Marina Galicia-Moreno, Jorge A Silva-Gomez, Silvia Lucano-Landeros, Arturo Santos, Hugo C Monroy-Ramirez, Juan Armendariz-Borunda, Yu-Chen Fan. Liver Cancer: Therapeutic Challenges and the Importance of Experimental Models. Canadian Journal of Gastroenterology and Hepatology 2021; 2021(1) doi: 10.1155/2021/8837811
|
| 353 |
Tracy Huang, Senlin Xu, Rucha Deo, An Ma, Hongzhi Li, Ke Ma, Xiaoxian Gan. Targeting the Ca2+/Calmodulin-dependent protein kinase II by Tetrandrine in human liver cancer cells. Biochemical and Biophysical Research Communications 2019; 508(4) doi: 10.1016/j.bbrc.2018.12.012
|
| 354 |
Nikhar Chhaniwal, Cheng Li, Jiaxiang Wang, Guosheng Qiang, Tingyue Qi, Hendi Maher. Hepatocellular Carcinoma: Review of Current Treatment with a Focus on Transarterial Chemoembolization and Radiofrequency Ablation. Open Journal of Radiology 2015; 5(01) doi: 10.4236/ojrad.2015.51009
|
| 355 |
Jing Xie, Aihua Zhang, Xijun Wang. Metabolomic applications in hepatocellular carcinoma: toward the exploration of therapeutics and diagnosis through small molecules. RSC Advances 2017; 7(28) doi: 10.1039/C7RA00698E
|
| 356 |
Khalid I. Bzeizi, Maheeba Abdullah, Kota Vidyasagar, Saleh A. Alqahthani, Dieter Broering. Hepatocellular Carcinoma Recurrence and Mortality Rate Post Liver Transplantation: Meta-Analysis and Systematic Review of Real-World Evidence. Cancers 2022; 14(20) doi: 10.3390/cancers14205114
|
| 357 |
Zhongwei Zhao, Jingjing Song, Dengke Zhang, Fazong Wu, Jianfei Tu, Jiansong Ji. Oxysophocarpine suppresses FGFR1-overexpressed hepatocellular carcinoma growth and sensitizes the therapeutic effect of lenvatinib. Life Sciences 2021; 264 doi: 10.1016/j.lfs.2020.118642
|
| 358 |
Xuesong Yao, Dong Yan, Huiying Zeng, Dengzhong Liu, Huai Li. Concurrent sorafenib therapy extends the interval to subsequent TACE for patients with unresectable hepatocellular carcinoma. Journal of Surgical Oncology 2016; 113(6) doi: 10.1002/jso.24215
|
| 359 |
Anusca Paixão, Rita Silva, Natália Lopes, Sónia Carvalho, Paulo Carrola, José Presa Ramos. Isolated Intracardiac Metastasis: The First Sign of Hepatocellular Carcinoma. GE - Portuguese Journal of Gastroenterology 2023; 30(1) doi: 10.1159/000519545
|
| 360 |
Qian Shen, Yanqiong Xia, Leilei Yang, Bo Wang, Jian Peng, Min Tang. Midazolam Suppresses Hepatocellular Carcinoma Cell Metastasis and Enhances Apoptosis by Elevating miR-217. Computational and Mathematical Methods in Medicine 2022; 2022 doi: 10.1155/2022/2813521
|
| 361 |
Zixi Wang, Tong Wu, Haixu Wang, Yawen Deng, Jing Liu, Tingting Wang, Xue Ren, Ying Sun, Haibo Zhang, Defu Yang, Feng Shang, Ying Xu, Dongyang Lv, Ying Yan. THBS1 as a candidate biomarker and fibrotic mediator in radiation-induced liver injury: insights from TMT-labeled quantitative proteomics. Frontiers in Pharmacology 2025; 16 doi: 10.3389/fphar.2025.1659870
|